DQA1 References
Assigned December 2022
Allele Name | Cell ID | HLA ID | Authors | Title | Journal | Year | Vol. | Pages | Contact |
---|---|---|---|---|---|---|---|---|---|
DQA1*01:01:01:01 | LG2 | HLA00601 | Horn GT, Bugawan TL, Long CM, Manos MM, Erlich HA | Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals | Human Immunology | 1988 | 21 | 249-263 | Dr. Henry Erlich |
DQA1*01:01:01:01 | BM.L | HLA00601 | Todd JA, Bell JI, McDevitt HO | HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus | Nature | 1987 | 329 | 599-604 | Dr. John A. Todd |
DQA1*01:01:01:01 | KAS116 | HLA00601 | Yasunaga S, Kimura A, Hamaguchi K, Ronningen KS, Sasazuki T | Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM) | Tissue Antigens | 1996 | 47 | 37-48 | Prof. Akinori Kimura |
DQA1*01:01:01:01 | #15310-LN | HLA00601 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*01:01:01:01 | JM02 | HLA00601 | Suzuki S, Ranade S, Osaki K, Iyo S, Shigenari A, Ohnuki Y, Oka A, Masuya A, Harting J, Baybayan P, Kitazume M, Sunaga J, Morishima S, Morishima Y, Inoko H, Kulski JK, Shiina T | Reference grade characterization of polymorphisms in full-length HLA class I and II genes with short-read sequencing on the ION PGM system and long-reads generated by single molecule, real-time sequencing on the PacBio platform | Frontiers in Immunology | 2018 | 9 | 2294- | Prof. Takashi Shiina |
DQA1*01:01:01:02 | VEN | HLA14786 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*01:01:01:03 | MYE 2006 | HLA14787 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*01:01:01:05 | JM10 | HLA17305 | Suzuki S, Ranade S, Osaki K, Iyo S, Shigenari A, Ohnuki Y, Oka A, Masuya A, Harting J, Baybayan P, Kitazume M, Sunaga J, Morishima S, Morishima Y, Inoko H, Kulski JK, Shiina T | Reference grade characterization of polymorphisms in full-length HLA class I and II genes with short-read sequencing on the ION PGM system and long-reads generated by single molecule, real-time sequencing on the PacBio platform | Frontiers in Immunology | 2018 | 9 | 2294- | Prof. Takashi Shiina |
DQA1*01:01:01:06 | FH11 | HLA22216 | Turner TR, Hayward DR, Gymer AW, Barker DJ, Leen G, Cambridge CA, Macpherson HL, Georgiou X, Cooper MA, Robinson J, Mayor NP, Marsh SGE | Widespread non-coding polymorphism in HLA class II genes of International HLA and Immunogenetics Workshop cell lines. | HLA | 2022 | 99 | 328-356 | Prof. Steven GE Marsh |
DQA1*01:01:01:07 | PAR GEE018 |
HLA23223 | Turner TR, Hayward DR, Gymer AW, Barker DJ, Leen G, Cambridge CA, Macpherson HL, Georgiou X, Cooper MA, Robinson J, Mayor NP, Marsh SGE | Widespread non-coding polymorphism in HLA class II genes of International HLA and Immunogenetics Workshop cell lines. | HLA | 2022 | 99 | 328-356 | Prof. Steven GE Marsh |
DQA1*01:01:01:08 | HLA-UERJ-1213055 | HLA26040 | Vianna R, Secco D, Santos A, Porto LC | Five novel HLA-DQA1*01 variants identified in Brazilian individuals | HLA | 2020 | 96 | 361-362 | Dr. Romulo Vianna |
DQA1*01:01:01:09 | DNA_43_Val_C | HLA26780 | Alizadeh M, Picard C, Frassati C, Walencik A, Cesbron Gauthier A, Bennasar F, Verite F, Semana G | A new set of reagents and related software used for NGS based classical and non-classical HLA tying showing evidence for a greater HLA haplotype diversity | Human Immunology | 2020 | 81 | 202-205 | Dr. Mehdi Alizadeh |
DQA1*01:01:01:10 | A3088D1 | HLA35633 | - | - | - | - | - | - | Dr. Meenakshi Singh |
DQA1*01:01:01:11 | A3060D3 | HLA36149 | - | - | - | - | - | - | Dr. Meenakshi Singh |
DQA1*01:01:01:12 | 202210037 | HLA36394 | - | - | - | - | - | - | Dr. Amalia Tejeda Velarde |
DQA1*01:01:02:01 | LWAGS PMG075 MZ070782 |
HLA01409 | - | - | - | - | - | - | Dr. M. L. Ashdown |
DQA1*01:01:02:01 | NA01018 | HLA01409 | Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S, Chang J, Palmieri A, Haugen E, Kaul R, Olson MV | Ancient haplotypes of the HLA Class II region | Genome Research | 2005 | 15 | 1250-1257 | Prof. Maynard Olson |
DQA1*01:01:02:02 | HLA-UERJ-3873991 | HLA27202 | Vianna R, Secco D, Santos A, Porto LC | The discovery of the first HLA-DQA1*01:01:02 variant, DQA1*01:01:02:02, found in a Brazilian individual | HLA | 2020 | 96 | 115-116 | Dr. Romulo Vianna |
DQA1*01:01:02:03 | 18-2973-CHP 18-2981-CHP |
HLA34240 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*01:01:03 | 41828 | HLA12906 | - | - | - | - | - | - | Prof. Marcel GJ Tilanus |
DQA1*01:01:04 | AN63 | HLA22489 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*01:01:04 | HG00021589 | HLA22489 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:01:05 | HG00021571 | HLA22707 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:01:05 | HG00016275 HG00018918 |
HLA22707 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:01:05 | HG00025333 | HLA22707 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:01:05 | 1910058659 | HLA22707 | Ralazamahaleo M, Andreani M, Giustiniani P, Guidicelli G, Visentin J | Characterization of the novel HLA-DQA1*01:01:05 allele by sequencing-based typing | HLA | 2019 | 94 | 172-173 | Dr. Jonathan Visentin |
DQA1*01:01:05 | 65170893284 | HLA22707 | - | - | - | - | - | - | Mr. Gerald Bertrand |
DQA1*01:01:05 | HG00015337 | HLA22707 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:01:06 | HG00021592 | HLA25793 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:01:07 | BARP6189 | HLA26782 | - | - | - | - | - | - | Mr. Vinicius Stelet |
DQA1*01:01:08 | 20215707 | HLA29029 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*01:01:08 | pv1068 | HLA29029 | Shi L, Li J, Yao Y, Shi L, Yang J | HLA-A*11:396, -B*55:112, and -DQA1*01:01:08 identified in individuals from the Zhuang population of China | HLA | 2021 | 98 | 148-150 | Prof. Li Shi |
DQA1*01:01:08 | HG00028857 | HLA29029 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:01:09:01 | KBNUH001 | HLA29691 | Chang SH, Ham JY, Moon JH, Won DI, Suh JS | Characterization of the novel DQA1*01:01:09 allele by next-generation sequencing | HLA | 2021 | 98 | 403-404 | Dr. Dongil Won |
DQA1*01:01:09:02 | 018000771 | HLA30828 | - | - | - | - | - | - | Mrs. Ornella Senoussi |
DQA1*01:01:10 | 1905511 | HLA29865 | Blandin L, Cargou M, Guidicelli G, Rouzaire P, Lemal R | Characterization of the novel HLA-DQA1*01:01:10 allele by sequencing-based typing | HLA | 2021 | 98 | 405-406 | Dr. Paul Rouzaire |
DQA1*01:01:11 | NGR0041 | HLA30515 | - | - | - | - | - | - | Dr. Laura Bungener |
DQA1*01:01:11 | HG00027191 | HLA30515 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:01:11 | HG00028876 | HLA30515 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:01:11 | HG00049898 | HLA30515 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:01:11 | HG00049884 | HLA30515 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:02:01:01 | LB | HLA00602 | Auffray C, Lillie JW, Arnot D, Grossberger D, Kappes D, Strominger JL | Isotypic and allotypic variation of human class II histocompatibility antigen alpha-chain genes | Nature | 1984 | 308 | 327-333 | Prof. Jack L Strominger |
DQA1*01:02:01:01 | CMCC | HLA00602 | Horn GT, Bugawan TL, Long CM, Manos MM, Erlich HA | Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals | Human Immunology | 1988 | 21 | 249-263 | Dr. Henry Erlich |
DQA1*01:02:01:01 | AZH DRA WT46 |
HLA00602 | Todd JA, Bell JI, McDevitt HO | HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus | Nature | 1987 | 329 | 599-604 | Dr. John A. Todd |
DQA1*01:02:01:01 | ROF-NL | HLA00602 | Lock CB, So AK, Welsh KI, Parkes JD, Trowsdale J | MHC class II sequences of an HLA-DR2 narcoleptic | Immunogenetics | 1988 | 27 | 449-455 | Prof. John Trowsdale |
DQA1*01:02:01:01 | EMJ | HLA00602 | Yasunaga S, Kimura A, Hamaguchi K, Ronningen KS, Sasazuki T | Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM) | Tissue Antigens | 1996 | 47 | 37-48 | Prof. Akinori Kimura |
DQA1*01:02:01:01 | NA10923 | HLA00602 | Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S, Chang J, Palmieri A, Haugen E, Kaul R, Olson MV | Ancient haplotypes of the HLA Class II region | Genome Research | 2005 | 15 | 1250-1257 | Prof. Maynard Olson |
DQA1*01:02:01:01 | 107-16 | HLA00602 | - | - | - | - | - | - | Dr. Reem Ameen |
DQA1*01:02:01:01 | 83-16 | HLA00602 | - | - | - | - | - | - | Dr. Reem Ameen |
DQA1*01:02:01:02 | NA00576 NA14663 |
HLA06598 | Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S, Chang J, Palmieri A, Haugen E, Kaul R, Olson MV | Ancient haplotypes of the HLA Class II region | Genome Research | 2005 | 15 | 1250-1257 | Prof. Maynard Olson |
DQA1*01:02:01:03 | NA14660 | HLA06594 | Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S, Chang J, Palmieri A, Haugen E, Kaul R, Olson MV | Ancient haplotypes of the HLA Class II region | Genome Research | 2005 | 15 | 1250-1257 | Prof. Maynard Olson |
DQA1*01:02:01:04 | NA14663 | HLA06599 | Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S, Chang J, Palmieri A, Haugen E, Kaul R, Olson MV | Ancient haplotypes of the HLA Class II region | Genome Research | 2005 | 15 | 1250-1257 | Prof. Maynard Olson |
DQA1*01:02:01:04 | KR-435 | HLA06599 | - | - | - | - | - | - | Dr. Reem Ameen |
DQA1*01:02:01:05 | PGF | HLA14846 | Horn GT, Bugawan TL, Long CM, Erlich HA | Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility | Proceedings of the National Academy of Sciences USA | 1988 | 85 | 6012-6016 | Dr. Henry Erlich |
DQA1*01:02:01:05 | PGF | HLA14846 | Stewart CA, Horton R, Allcock RJ, Ashurst JL, Atrazhev AM, Coggill P, Dunham I, Forbes S, Halls K, Howson JM, Humphray SJ, Hunt S, Mungall AJ, Osoegawa K, Palmer S, Roberts AN, Rogers J, Sims S, Wang Y, Wilming LG, Elliott JF, de Jong PJ, Sawcer S, Todd JA, Trowsdale J, Beck S | Complete MHC haplotype sequencing for common disease gene mapping | Genome Research | 2004 | 14 | 1176-1187 | Prof. Stephan Beck |
DQA1*01:02:01:05 | PGF | HLA14846 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*01:02:01:06 | LEO23 | HLA14847 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*01:02:01:07 | RD-DJ | HLA14848 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*01:02:01:08 | T253 | HLA17306 | Suzuki S, Ranade S, Osaki K, Iyo S, Shigenari A, Ohnuki Y, Oka A, Masuya A, Harting J, Baybayan P, Kitazume M, Sunaga J, Morishima S, Morishima Y, Inoko H, Kulski JK, Shiina T | Reference grade characterization of polymorphisms in full-length HLA class I and II genes with short-read sequencing on the ION PGM system and long-reads generated by single molecule, real-time sequencing on the PacBio platform | Frontiers in Immunology | 2018 | 9 | 2294- | Prof. Takashi Shiina |
DQA1*01:02:01:09 | HOR | HLA17770 | - | - | - | - | - | - | Dr. Mehdi Alizadeh |
DQA1*01:02:01:10 | AN36 | HLA20634 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*01:02:01:11 | AN90 | HLA22355 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*01:02:01:12 | EMJ | HLA22659 | Turner TR, Hayward DR, Gymer AW, Barker DJ, Leen G, Cambridge CA, Macpherson HL, Georgiou X, Cooper MA, Robinson J, Mayor NP, Marsh SGE | Widespread non-coding polymorphism in HLA class II genes of International HLA and Immunogenetics Workshop cell lines. | HLA | 2022 | 99 | 328-356 | Prof. Steven GE Marsh |
DQA1*01:02:01:13 | AN32 | HLA22978 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*01:02:01:14 | HLA-UERJ-100770 | HLA25721 | Vianna R, Secco D, Santos A, Porto LC | Five novel HLA-DQA1*01 variants identified in Brazilian individuals | HLA | 2020 | 96 | 361-362 | Dr. Romulo Vianna |
DQA1*01:02:01:15 | HLA-UERJ-C11222 | HLA29362 | Vianna R, Lopes G, Porto LC | Three novel HLA-DQA1 alleles identified in Brazilian individuals by next-generation sequencing | HLA | 2021 | 98 | 74-75 | Dr. Romulo Vianna |
DQA1*01:02:01:16 | 18-2946-CHP 18-4948-CHP |
HLA33694 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*01:02:01:17 | 18-2949-CHP | HLA33836 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*01:02:01:18 | 18-3065-CHP | HLA33849 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*01:02:01:19 | 18-5027-CHP 18-5032-CHP |
HLA33870 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*01:02:01:20 | 18-5038-CHP | HLA33888 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*01:02:01:21 | 18-5097-CHP 18-5106-CHP |
HLA33866 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*01:02:01:21 | AN301075 | HLA33866 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*01:02:01:22 | 18-2979-CHP | HLA33850 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*01:02:01:23 | 18-4941-CHP 18-5010-CHP |
HLA34020 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*01:02:01:24 | 18-4990-CHP 18-4991-CHP |
HLA34141 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*01:02:01:25 | 18-3084-CHP | HLA34127 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*01:02:01:26 | 18-2781-CHP 18-2799-CHP 18-2803-CHP 18-2805-CHP 18-4344-CHP |
HLA34172 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*01:02:01:27 | 18-2979-CHP 18-4949-CHP |
HLA34233 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*01:02:02:01 | KAS011 | HLA00603 | Yasunaga S, Kimura A, Hamaguchi K, Ronningen KS, Sasazuki T | Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM) | Tissue Antigens | 1996 | 47 | 37-48 | Prof. Akinori Kimura |
DQA1*01:02:02:01 | HS67 | HLA00603 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*01:02:02:02 | AN66 | HLA20892 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*01:02:02:03 | AN29 | HLA22291 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*01:02:02:04 | WJR076 | HLA22737 | Turner TR, Hayward DR, Gymer AW, Barker DJ, Leen G, Cambridge CA, Macpherson HL, Georgiou X, Cooper MA, Robinson J, Mayor NP, Marsh SGE | Widespread non-coding polymorphism in HLA class II genes of International HLA and Immunogenetics Workshop cell lines. | HLA | 2022 | 99 | 328-356 | Prof. Steven GE Marsh |
DQA1*01:02:02:05 | HLA-UERJ-98516 | HLA25368 | Vianna R, Secco D, Santos A, Porto LC | Five novel HLA-DQA1*01 variants identified in Brazilian individuals | HLA | 2020 | 96 | 361-362 | Dr. Romulo Vianna |
DQA1*01:02:02:06 | AZH | HLA30510 | Turner TR, Hayward DR, Gymer AW, Barker DJ, Leen G, Cambridge CA, Macpherson HL, Georgiou X, Cooper MA, Robinson J, Mayor NP, Marsh SGE | Widespread non-coding polymorphism in HLA class II genes of International HLA and Immunogenetics Workshop cell lines. | HLA | 2022 | 99 | 328-356 | Prof. Steven GE Marsh |
DQA1*01:02:03 | BM3171 | HLA02338 | Lee KW, Jung YA, Oh DH | Four novel human leukocyte antigen-DQA1 alleles identified in the Korean population | Tissue Antigens | 2006 | 68 | 167-172 | Dr. Kyung Wha Lee |
DQA1*01:02:04 | 24368 | HLA02432 | Voorter CEM, van den Berg-Loonen EM | Sequence-based typing of the complete coding sequence of DQA1 and phenotype frequencies in the Dutch Caucasian population | Human Immunology | 2006 | 67 | 756-763 | Prof. Ella M. Van den Berg-Loonen |
DQA1*01:02:05 | 60793651 | HLA22816 | Planelles D, Balas A, Rodríguez-Cebriá M, Moreno-Hidalgo MA, Vicario JL | Characterization of seven new HLA alleles, A*24:14:01:04, A*29:02:01:07, C*06:02:01:37, C*07:830, C*16:162, C*16:01:01:07, and DQA1*01:02:05 | HLA | 2019 | 94 | 521-522 | Dr. Antonio Balas |
DQA1*01:02:06 | 31575 | HLA25296 | Ingram KJ, O’Shields EF, Kiger D, Gautreaux MD | NGS and HLA: The long road ahead | Human Immunology | 2020 | 81 | 280-284 | Dr. Michael Gautreaux |
DQA1*01:02:07 | HG00024952 | HLA25682 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:02:08 | HG00025332 | HLA26160 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:02:09 | 33352 | HLA27318 | Ingram KJ, O'Shields EF, Kiger DF, Netherton EM, Gautreaux MD | Identification of novel HLA alleles discovered in 2019-2021 | Human Immunology | 2021 | 82 | 982-984 | Dr. Michael Gautreaux |
DQA1*01:02:10 | 20207047 | HLA29262 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*01:02:11 | 2110071256 | HLA31204 | Cargou M, Andreani M, Battarra M, Wojciechowski E, Visentin J | Characterization of the novel HLA-DQA1*01:02:11 allele by sequencing-based typing | HLA | 2021 | 98 | 566-568 | Dr. Jonathan Visentin |
DQA1*01:02:12 | HG00028854 | HLA32129 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:02:12 | HG00029401 | HLA32129 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:02:13:01 | 211809772 | HLA33927 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*01:02:13:02 | 211800310 | HLA34327 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*01:02:13:03 | 41642241 | HLA34452 | - | - | - | - | - | - | Dr. Romain Ferru-Clement |
DQA1*01:02:14 | 211709614 | HLA33909 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*01:02:14 | 108861 | HLA33909 | - | - | - | - | - | - | Dr. Francisco de Paula Sanchez Gordo |
DQA1*01:02:15 | VGH016 | HLA36425 | - | - | - | - | - | - | Dr. Jenny Tran |
DQA1*01:02:16 | VGH020 | HLA36491 | - | - | - | - | - | - | Dr. Jenny Tran |
DQA1*01:02:17 | 22S176 | HLA36806 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*01:02:18 | 22S177 | HLA36912 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*01:03:01:01 | WDV | HLA00604 | Todd JA, Bell JI, McDevitt HO | HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus | Nature | 1987 | 329 | 599-604 | Dr. John A. Todd |
DQA1*01:03:01:01 | APD FPAF TAB089 |
HLA00604 | Horn GT, Bugawan TL, Long CM, Erlich HA | Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility | Proceedings of the National Academy of Sciences USA | 1988 | 85 | 6012-6016 | Dr. Henry Erlich |
DQA1*01:03:01:01 | 2012 | HLA00604 | Lee KW, Johnson AH, Hurley CK | Two divergent routes of evolution gave rise to the DRw13 haplotypes | Journal of Immunology | 1990 | 145 | 3119-3125 | Prof. Carolyn K Hurley |
DQA1*01:03:01:01 | E4181324 | HLA00604 | Yasunaga S, Kimura A, Hamaguchi K, Ronningen KS, Sasazuki T | Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM) | Tissue Antigens | 1996 | 47 | 37-48 | Prof. Akinori Kimura |
DQA1*01:03:01:01 | NA03715 | HLA00604 | Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S, Chang J, Palmieri A, Haugen E, Kaul R, Olson MV | Ancient haplotypes of the HLA Class II region | Genome Research | 2005 | 15 | 1250-1257 | Prof. Maynard Olson |
DQA1*01:03:01:02 | NA03715 | HLA06601 | Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S, Chang J, Palmieri A, Haugen E, Kaul R, Olson MV | Ancient haplotypes of the HLA Class II region | Genome Research | 2005 | 15 | 1250-1257 | Prof. Maynard Olson |
DQA1*01:03:01:02 | KR-300 | HLA06601 | - | - | - | - | - | - | Dr. Reem Ameen |
DQA1*01:03:01:02 | APD | HLA06601 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*01:03:01:03 | IHL, AD036 | HLA14788 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*01:03:01:04 | HS67 | HLA14789 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*01:03:01:05 | KE | HLA14790 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*01:03:01:06 | MYE 2003 | HLA14791 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*01:03:01:07 | T063 | HLA17307 | Suzuki S, Ranade S, Osaki K, Iyo S, Shigenari A, Ohnuki Y, Oka A, Masuya A, Harting J, Baybayan P, Kitazume M, Sunaga J, Morishima S, Morishima Y, Inoko H, Kulski JK, Shiina T | Reference grade characterization of polymorphisms in full-length HLA class I and II genes with short-read sequencing on the ION PGM system and long-reads generated by single molecule, real-time sequencing on the PacBio platform | Frontiers in Immunology | 2018 | 9 | 2294- | Prof. Takashi Shiina |
DQA1*01:03:01:08 | JM35 | HLA17308 | Suzuki S, Ranade S, Osaki K, Iyo S, Shigenari A, Ohnuki Y, Oka A, Masuya A, Harting J, Baybayan P, Kitazume M, Sunaga J, Morishima S, Morishima Y, Inoko H, Kulski JK, Shiina T | Reference grade characterization of polymorphisms in full-length HLA class I and II genes with short-read sequencing on the ION PGM system and long-reads generated by single molecule, real-time sequencing on the PacBio platform | Frontiers in Immunology | 2018 | 9 | 2294- | Prof. Takashi Shiina |
DQA1*01:03:01:09 | OMW AN72 DAUDI |
HLA22321 | Turner TR, Hayward DR, Gymer AW, Barker DJ, Leen G, Cambridge CA, Macpherson HL, Georgiou X, Cooper MA, Robinson J, Mayor NP, Marsh SGE | Widespread non-coding polymorphism in HLA class II genes of International HLA and Immunogenetics Workshop cell lines. | HLA | 2022 | 99 | 328-356 | Prof. Steven GE Marsh |
DQA1*01:03:01:10 | HLA-UERJ-97940 | HLA25775 | Vianna R, Secco D, Santos A, Porto LC | Five novel HLA-DQA1*01 variants identified in Brazilian individuals | HLA | 2020 | 96 | 361-362 | Dr. Romulo Vianna |
DQA1*01:03:01:10 | KR-392 | HLA25775 | - | - | - | - | - | - | Dr. Reem Ameen |
DQA1*01:03:01:11 | DNA_7_Val_C | HLA26819 | Alizadeh M, Picard C, Frassati C, Walencik A, Cesbron Gauthier A, Bennasar F, Verite F, Semana G | A new set of reagents and related software used for NGS based classical and non-classical HLA tying showing evidence for a greater HLA haplotype diversity | Human Immunology | 2020 | 81 | 202-205 | Dr. Mehdi Alizadeh |
DQA1*01:03:01:12 | NATL11 | HLA28654 | - | - | - | - | - | - | Prof. Takashi Shiina |
DQA1*01:03:01:13 | A2987D1 | HLA36064 | - | - | - | - | - | - | Dr. Meenakshi Singh |
DQA1*01:03:02 | HG00021579 | HLA23306 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:03:02 | HG00025330 | HLA23306 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:03:02 | HG00025448 | HLA23306 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:03:03 | 34056 | HLA27775 | Ingram KJ, O'Shields EF, Kiger DF, Netherton EM, Gautreaux MD | Identification of novel HLA alleles discovered in 2019-2021 | Human Immunology | 2021 | 82 | 982-984 | Dr. Michael Gautreaux |
DQA1*01:03:03 | 111402360 | HLA27775 | - | - | - | - | - | - | Dr. Francesc Rudilla |
DQA1*01:03:04 | 20205105 | HLA27601 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*01:03:05 | HG00028820 | HLA30482 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:03:06 | 22S134 | HLA34026 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*01:03:07 | YUMC007 | HLA35574 | - | - | - | - | - | - | Dr. Yoonhee Park |
DQA1*01:03:08 | 900612290145126 | HLA36787 | - | - | - | - | - | - | Prof. Faming Zhu |
DQA1*01:04:01:01 | 2012 2013 |
HLA00605 | Lee KW, Johnson AH, Hurley CK | New DQw1 diversity identified within DRw12 and DRw14 haplotypes | Tissue Antigens | 1991 | 38 | 231-234 | Prof. Carolyn K Hurley |
DQA1*01:04:01:01 | EK DEK REN KOSE 31227ABO |
HLA00605 | Fogdell A, Olerup O | The DQA1*0104 allele is carried by DRB1*1001- and DRB1*1401-positive haplotypes in Caucasians, Africans and Orientals | Tissue Antigens | 1994 | 44 | 19-24 | Dr. Olle Olerup |
DQA1*01:04:01:01 | EK | HLA00605 | Yasunaga S, Kimura A, Hamaguchi K, Ronningen KS, Sasazuki T | Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM) | Tissue Antigens | 1996 | 47 | 37-48 | Prof. Akinori Kimura |
DQA1*01:04:01:01 | NA10540 | HLA00605 | Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S, Chang J, Palmieri A, Haugen E, Kaul R, Olson MV | Ancient haplotypes of the HLA Class II region | Genome Research | 2005 | 15 | 1250-1257 | Prof. Maynard Olson |
DQA1*01:04:01:02 | NA04535 | HLA06597 | Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S, Chang J, Palmieri A, Haugen E, Kaul R, Olson MV | Ancient haplotypes of the HLA Class II region | Genome Research | 2005 | 15 | 1250-1257 | Prof. Maynard Olson |
DQA1*01:04:01:03 | THA | HLA14792 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*01:04:01:04 | HAY, BD | HLA14793 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*01:04:01:05 | 24814773 | HLA36741 | - | - | - | - | - | - | Dr. Luis A. Marin |
DQA1*01:04:02:01 | KGU | HLA01376 | Perez-Rodriguez M, Madrigal JA, Marsh SGE | A novel HLA-DQA1 allele, DQA1*01042 | Tissue Antigens | 2002 | 59 | 440-442 | Prof. Steven GE Marsh |
DQA1*01:04:02:01 | AN44 | HLA01376 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*01:04:02:02 | 0096UB001449-AD-176-515-716 | HLA33497 | - | - | - | - | - | - | Dr. Yoginder Pal Singh |
DQA1*01:04:03 | HG00026777 | HLA28202 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:04:04 | P13774 | HLA33295 | - | - | - | - | - | - | Prof. Faming Zhu |
DQA1*01:04:05 | 2022S104 | HLA34151 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*01:04:06 | 5946422-259305 | HLA36240 | - | - | - | - | - | - | Dr. Neifi Hassan Saloum Deghaide |
DQA1*01:04:07 | 201401736 201500882 |
HLA36300 | - | - | - | - | - | - | Dr. Amalia Tejeda Velarde |
DQA1*01:04:08 | VGH019 | HLA36488 | - | - | - | - | - | - | Dr. Jenny Tran |
DQA1*01:04:09 | JH0053 | HLA36724 | - | - | - | - | - | - | Dr. Maria Bettinotti |
DQA1*01:05:01:01 | AK93007 | HLA00606 | Yasunaga S, Kimura A, Hamaguchi K, Ronningen KS, Sasazuki T | Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM) | Tissue Antigens | 1996 | 47 | 37-48 | Dr. Shin'ichiro Yasunaga |
DQA1*01:05:01:01 | 1183 2708 |
HLA00606 | Lee KW, Johnson AH, Hurley CK | New DQw1 diversity identified within DRw12 and DRw14 haplotypes | Tissue Antigens | 1991 | 38 | 231-234 | Prof. Carolyn K Hurley |
DQA1*01:05:01:01 | NA14660 | HLA00606 | Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S, Chang J, Palmieri A, Haugen E, Kaul R, Olson MV | Ancient haplotypes of the HLA Class II region | Genome Research | 2005 | 15 | 1250-1257 | Prof. Maynard Olson |
DQA1*01:05:01:01 | REN | HLA00606 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*01:05:01:02 | HLA-UERJ-101846 | HLA24530 | Vianna R, Secco D, Santos A, Porto LC | Characterization of the first HLA-DQA1*01:05:01 variant, DQA1*01:05:01:02, found in a Brazilian individual | HLA | 2019 | 94 | 465-466 | Dr. Romulo Vianna |
DQA1*01:05:01:03 | HLA-UERJ-103328 | HLA26983 | Vianna R, Secco D, Santos A, Porto LC | Five novel HLA-DQA1*01 variants identified in Brazilian individuals | HLA | 2020 | 96 | 361-362 | Dr. Romulo Vianna |
DQA1*01:05:02:01 | 224036 | HLA11066 | - | - | - | - | - | - | Dr. Klaus Witter |
DQA1*01:05:02:02 | 17-3457-CHP 18-4971-CHP 18-4988-CHP 18-4991-CHP 18-4992-CHP |
HLA34140 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*01:05:03 | AHUS0001 | HLA26679 | Mahmood F, Saether PC | A novel HLA-DQA1 allele, DQA1*01:05:03, identified in a patient with suspected celiac disease | HLA | 2020 | 96 | 117-118 | Dr. Per Christian Saether |
DQA1*01:05:03 | HG00016274 | HLA26679 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:05:03 | HG00021590 | HLA26679 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:05:04 | 6034522-267774 | HLA36914 | - | - | - | - | - | - | Dr. Neifi Hassan Saloum Deghaide |
DQA1*01:06 | 183 | HLA01003 | Luo M, Blanchard J, Maclean I, Brunham R | Identification of a novel HLA-DQA1 allele (DQA1*0106) by sequence-based DQA1 typing | Tissue Antigens | 1999 | 53 | 595-596 | Dr. Ma Luo |
DQA1*01:06 | 22000180 | HLA01003 | - | - | - | - | - | - | Dr. Lotte Wieten |
DQA1*01:07Q | CDC033104 | HLA01905 | Hancock LN, Cordovado SK, Hendrix M, Simone AE, Mueller PW | Identification of two novel DQA1 alleles, DQA1*0107 and DQA1*0602, by sequence-based typing in the GoKinD population | Human Immunology | 2005 | 66 | 1248-1253 | Dr. Suzanne Cordovado |
DQA1*01:07Q | EBV-II-2 | HLA01905 | Lardy NM, Otting N, van der Horst AR, Bontrop RE, de Waal LP | Full-length cDNA nucleotide sequence of a serologically undetectable HLA-DQA1 allele: HLA-DQA1*"LA" | Tissue Antigens | 1997 | 50 | 334-339 | Dr. Neubury M. Lardy |
DQA1*01:07Q | KMP | HLA01905 | Miyadera H, Bungener LB, Kusano S, Yokoyama S, Tokunaga K, Hepkema BG | Questionable expression of unstable DQ heterodimer containing HLA-DQA1*01:07 | Tissue Antigens | 2015 | 86 | 413-418 | Dr. Bouke Hepkema |
DQA1*01:07Q | 215443 | HLA01905 | Witter K, Halliwell JA, Mautner J, Jolesch A, von Welser G, Rampp I, Spannagl M, Kauke T, Dick A | Group-specific amplification of HLA-DQA1 revealed a number of genomic full length sequences including the novel HLA alleles DQA1*01:10 and DQA1*01:11 | Tissue Antigens | 2014 | 83 | 49-51 | Dr. Klaus Witter |
DQA1*01:08 | 1923 | HLA07277 | Yan H, Liu X, Dong X, Li J, An P, Zhao L, Han F | Identification of three novel HLA-DQA1 alleles, DQA1*01:08, DQA1*01:09 and DQA1*03:03:02 | Tissue Antigens | 2012 | 80 | 551-553 | Prof. Fang Han |
DQA1*01:09 | 2146 | HLA07278 | Yan H, Liu X, Dong X, Li J, An P, Zhao L, Han F | Identification of three novel HLA-DQA1 alleles, DQA1*01:08, DQA1*01:09 and DQA1*03:03:02 | Tissue Antigens | 2012 | 80 | 551-553 | Prof. Fang Han |
DQA1*01:10 | 214622 | HLA08431 | Witter K, Halliwell JA, Mautner J, Jolesch A, von Welser G, Rampp I, Spannagl M, Kauke T, Dick A | Group-specific amplification of HLA-DQA1 revealed a number of genomic full length sequences including the novel HLA alleles DQA1*01:10 and DQA1*01:11 | Tissue Antigens | 2014 | 83 | 49-51 | Dr. Klaus Witter |
DQA1*01:11 | 214965 | HLA08433 | Witter K, Halliwell JA, Mautner J, Jolesch A, von Welser G, Rampp I, Spannagl M, Kauke T, Dick A | Group-specific amplification of HLA-DQA1 revealed a number of genomic full length sequences including the novel HLA alleles DQA1*01:10 and DQA1*01:11 | Tissue Antigens | 2014 | 83 | 49-51 | Dr. Klaus Witter |
DQA1*01:12 | R44096 | HLA09875 | Adamek M, Klages C, Bauer M, Kudlek E, Drechsler A, Leuser B, Scherer S, Opelz G, Tran TH | Seven novel HLA alleles reflect different mechanisms involved in the evolution of HLA diversity: Description of the new alleles and review of the literature | Human Immunology | 2015 | 76 | 30-35 | Dr. Hien Tran |
DQA1*01:12 | 20205481 | HLA09875 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*01:13 | 60753693 | HLA14208 | Balas A, Planelles D, García-Sánchez F, Prior C, Vicario JL | Three new HLA class II alleles: DRB1*08:70, DQA1*01:13 and DQA1*03:01:03 | International Journal of Immunogenetics | 2016 | 43 | 107-108 | Dr. Antonio Balas |
DQA1*01:14 | RDP-CH4-28 | HLA15632 | Hou L, Vierra-Green C, Lazaro A, Brady C, Haagenson M, Spellman S, Hurley CK | Limited HLA sequence variation outside of antigen recognition domain exons of 360 10 of 10 matched unrelated hematopoietic stem cell transplant donor-recipient pairs | HLA | 2017 | 89 | 39-46 | Prof. Carolyn K Hurley |
DQA1*01:15N | IME 956-16 | HLA16313 | Battarra M, Condello R, Testi M, Stellotano C, Andreani M | Identification of the new HLA-DQA1*01:15N allele in an Italian patient | HLA | 2017 | 90 | 130-131 | Dr. Mariarosa Battarra |
DQA1*01:16N | UA2017tp865 | HLA17279 | - | - | - | - | - | - | Dr. Mats Bengtsson |
DQA1*01:17 | HG00017253 | HLA21081 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:18 | 29659 | HLA21420 | Ingram KJ, Merkens H, O’Shields EF, Kiger D, Gautreaux MD | New HLA alleles discovered by NGS in routine lab work in a medium-volume HLA laboratory | Human Immunology | 2019 | 80 | 465-467 | Dr. Michael Gautreaux |
DQA1*01:19 | 29695 | HLA21186 | Ingram KJ, Merkens H, O’Shields EF, Kiger D, Gautreaux MD | New HLA alleles discovered by NGS in routine lab work in a medium-volume HLA laboratory | Human Immunology | 2019 | 80 | 465-467 | Dr. Michael Gautreaux |
DQA1*01:19 | 1118012932 | HLA21186 | Genebrier S, Rouzaire P, Nivet C, Chérel M, Renac V | Characterization of the novel HLA-DQA1*01:19 allele by next-generation sequencing | HLA | 2021 | 97 | 250-251 | Mr. Gerald Bertrand |
DQA1*01:20 | HG00021594 | HLA21310 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:20 | HG00021565 | HLA21310 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:20 | 29907 | HLA21310 | Ingram KJ, Merkens H, O’Shields EF, Kiger D, Gautreaux MD | New HLA alleles discovered by NGS in routine lab work in a medium-volume HLA laboratory | Human Immunology | 2019 | 80 | 465-467 | Dr. Michael Gautreaux |
DQA1*01:21 | 30057 | HLA21743 | Ingram KJ, Merkens H, O’Shields EF, Kiger D, Gautreaux MD | New HLA alleles discovered by NGS in routine lab work in a medium-volume HLA laboratory | Human Immunology | 2019 | 80 | 465-467 | Dr. Michael Gautreaux |
DQA1*01:22 | 4258255 | HLA21953 | Cargou M, Andreani M, Troiano M, Guidicelli G, Visentin J | Characterization of the novel HLA-DQA1*01:22 allele by sequencing-based typing | HLA | 2019 | 94 | 333-334 | Dr. Jonathan Visentin |
DQA1*01:22 | 4306449 | HLA21953 | Cargou M, Andreani M, Troiano M, Guidicelli G, Visentin J | Characterization of the novel HLA-DQA1*01:22 allele by sequencing-based typing | HLA | 2019 | 94 | 333-334 | Dr. Jonathan Visentin |
DQA1*01:23 | 18222788 | HLA22385 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*01:24 | AN86 | HLA22517 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*01:25 | HG00018151 | HLA22781 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:25 | 4286767 | HLA22781 | Cargou M, Andreani M, Galluccio T, Guidicelli G, Visentin J | Characterization of the novel HLA-DQA1*01:25 allele by sequencing-based typing | HLA | 2019 | 94 | 174-175 | Dr. Jonathan Visentin |
DQA1*01:25 | DNA-08-BES | HLA22781 | - | - | - | - | - | - | Dr. Mehdi Alizadeh |
DQA1*01:26 | LIT302-19 | HLA22794 | Battarra M M, Guagnano A, Testa G, Di Luzio A, Andreani M | A new HLA-DQA1 allele, HLA-DQA1*01:26 | HLA | 2020 | 96 | 119-120 | Dr. Mariarosa Battarra |
DQA1*01:27 | 4319609 | HLA22924 | Ralazamahaleo M, Andreani M, Di Luzio A, Guidicelli G, Visentin J | Characterization of the novel HLA-DQA1*01:27 allele by sequencing-based typing | HLA | 2019 | 94 | 392-394 | Dr. Jonathan Visentin |
DQA1*01:27 | HG00021588 | HLA22924 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:28 | HG00021587 | HLA23329 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:29 | HG00021593 | HLA23183 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:30 | HG00021580 | HLA23181 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:30 | HG00021566 HG00024954 |
HLA23181 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:30 | 93116216 | HLA23181 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*01:30 | UHB0002 | HLA23181 | - | - | - | - | - | - | Mr. Marc Kleiser |
DQA1*01:31 | HG00021583 | HLA23388 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:31 | HG00021574 HG00021575 HG00021576 |
HLA23388 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:32 | HG00015335 | HLA24010 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:33 | HG00018916 | HLA24011 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:34 | HG00018917 | HLA24159 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:35 | HG00018919 HG00018920 |
HLA24206 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:36 | HG00021584 HG00021585 |
HLA24078 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:37 | HG00022433 | HLA24095 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:38:01:01 | 1117018172 | HLA24286 | Genebrier S, Lemal R, Nivet C, Chérel M, Renac V | Characterization of the novel HLA-DQA1*01:38:01:01 allele by next-generation sequencing | HLA | 2021 | 97 | 252-253 | Mr. Gerald Bertrand |
DQA1*01:38:01:01 | 017360064 | HLA24286 | - | - | - | - | - | - | Mrs. Ornella Senoussi |
DQA1*01:38:01:02 | 19-10-16-ADN3Bes | HLA26526 | - | - | - | - | - | - | Dr. Mehdi Alizadeh |
DQA1*01:39 | 65181656778 | HLA24279 | Genebrier S, Rouzaire P, Texeraud E, Bertrand G, Renac V | Characterization of the novel HLA-DQA1*01:39 allele by next-generation sequencing | HLA | 2021 | 98 | 240-241 | Mr. Gerald Bertrand |
DQA1*01:40Q | HG00024953 | HLA25178 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:41 | 19210518 | HLA24556 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*01:42 | HG00026344 | HLA24998 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:42 | 31718 | HLA24998 | Ingram KJ, O’Shields EF, Kiger D, Gautreaux MD | NGS and HLA: The long road ahead | Human Immunology | 2020 | 81 | 280-284 | Dr. Michael Gautreaux |
DQA1*01:42 | HG00028867 HG00028871 HG00028872 HG00028881 HG00028887 |
HLA24998 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:43 | 19213824 | HLA25799 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*01:43 | UOU0010 UOU0011 |
HLA25799 | - | - | - | - | - | - | Dr. Eszter Lazar-Molnar |
DQA1*01:43 | HG00031302 | HLA25799 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:44 | 017269679 | HLA26391 | - | - | - | - | - | - | Mrs. Ornella Senoussi |
DQA1*01:45 | 19168006157 | HLA26826 | Gareau A, Abu-Khader A, Yang G, Stamm L, Berka N | Four novel HLA class II alleles identified using next-generation sequencing | HLA | 2021 | 98 | 233-234 | Dr. Alison Gareau |
DQA1*01:45 | BARP6281 | HLA26826 | - | - | - | - | - | - | Mr. Vinicius Stelet |
DQA1*01:45 | 111427372 | HLA26826 | - | - | - | - | - | - | Dr. Francesc Rudilla |
DQA1*01:45 | 016377907 | HLA26826 | - | - | - | - | - | - | Mrs. Ornella Senoussi |
DQA1*01:45 | HG00029404 | HLA26826 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:46 | 111385900 | HLA26874 | - | - | - | - | - | - | Dr. Francesc Rudilla |
DQA1*01:47 | HG00026343 | HLA27217 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:48 | 1910965281 | HLA26966 | Cargou M, Andreani M, Testa G, Guidicelli G, Visentin J | Characterization of the novel HLA-DQA1*01:48 allele by sequencing-based typing | HLA | 2020 | 96 | 362-364 | Dr. Jonathan Visentin |
DQA1*01:49 | 1910764616 | HLA27536 | Cargou M, Andreani M, Locatelli F, Blouin L, Visentin J | Characterization of the novel HLA-DQA1*01:49 allele by sequencing-based typing | HLA | 2020 | 96 | 232-234 | Dr. Jonathan Visentin |
DQA1*01:50 | 111386598 | HLA28432 | - | - | - | - | - | - | Dr. Francesc Rudilla |
DQA1*01:51:01:01 | GLAS75116 | HLA28782 | - | - | - | - | - | - | Dr. Claire Walker |
DQA1*01:51:01:02 | NGR0038a | HLA33910 | - | - | - | - | - | - | Dr. Laura Bungener |
DQA1*01:51:01:02 | NGR0038b | HLA33910 | - | - | - | - | - | - | Dr. Laura Bungener |
DQA1*01:52 | UHB0005 | HLA28694 | - | - | - | - | - | - | Mr. Marc Kleiser |
DQA1*01:53 | 20205800 | HLA29213 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*01:54 | scu15974 | HLA29275 | - | - | - | - | - | - | Dr. Francisco de Paula Sanchez Gordo |
DQA1*01:54 | SCU10808 | HLA29275 | - | - | - | - | - | - | Dr. Francisco de Paula Sanchez Gordo |
DQA1*01:55 | HG00028891 | HLA29427 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:56 | HG00028855 | HLA29466 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:57 | 20225117 | HLA29380 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*01:58 | 2010922511 | HLA29785 | Cargou M, Andreani M, Battarra M, Wojciechowski E, Visentin J | Characterization of the novel HLA-DQA1*01:58 allele by sequencing-based typing | HLA | 2021 | 98 | 76-77 | Dr. Jonathan Visentin |
DQA1*01:59 | HG00028823 | HLA30089 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:59 | HG00031395 | HLA30089 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:60 | HG00028861 | HLA30451 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:60 | HG00030101 HG00030108 HG00030114 HG00030115 |
HLA30451 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:60 | HG00031308 | HLA30451 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:60 | HG00050731 | HLA30451 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:61 | HG00028878 | HLA30303 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:62 | HG00028833 | HLA30337 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:63:01:01 | 18-2977-CHP 18-4962-CHP |
HLA30382 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*01:63:01:01 | KUHSC-15-21 | HLA30382 | - | - | - | - | - | - | Dr. Reem Ameen |
DQA1*01:63:01:01 | HG00028830 HG00028870 |
HLA30382 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:63:01:01 | HG00028869 | HLA30382 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:63:01:01 | HG00029942 HG00029943 HG00029944 HG00029945 HG00029946 HG00029947 HG00029948 HG00029949 HG00029950 HG00029951 HG00029952 HG00029953 HG00029954 |
HLA30382 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:63:01:01 | HG00029929 HG00029931 HG00029933 |
HLA30382 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:63:01:01 | HG00031495 | HLA30382 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:63:01:02 | 22S126 | HLA34148 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*01:64 | 017251362 | HLA29878 | - | - | - | - | - | - | Mrs. Ornella Senoussi |
DQA1*01:65 | 7631-3 | HLA30535 | Hald J, Plesner A, Hauge AW, Bruunsgaard H | Detection of the novel HLA allele, HLA-DQA1*01:65, identified in a Danish donor. | HLA | 2022 | 99 | 66-67 | Dr. Annette Plesner |
DQA1*01:66 | 018015301 | HLA30823 | - | - | - | - | - | - | Mrs. Ornella Senoussi |
DQA1*01:67 | HG00029390 | HLA31328 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:68 | HG00029392 | HLA31304 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:69 | HG00029394 | HLA30883 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:70 | HG00029686 | HLA31377 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:71 | HG00029687 | HLA31454 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:72 | HG00030010 | HLA31635 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:73 | HG00029993 | HLA31535 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:73 | HG00031289 | HLA31535 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:74 | HG00030007 | HLA31564 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:75 | HG00030001 | HLA31607 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:75 | HG00031618 | HLA31607 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:76 | 2110248617 | HLA31989 | Cargou M, Andreani M, Bianculli AG, Ralazamahaleo M, Visentin J | Characterization of the novel HLA-DQA1*01:76 allele by sequencing-based typing. | HLA | 2022 | 99 | 136-137 | Dr. Jonathan Visentin |
DQA1*01:77 | HG00030103 | HLA32124 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:78 | HG00030094 | HLA32023 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:79 | HG00030107 | HLA31969 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:80 | Amiens04 | HLA32194 | Jacob V, Farce F, Kaveri R, Desoutter J, Guillaume N | Characterization of the novel HLA-DQA1*01:80 allele by next generation sequencing. | HLA | 2022 | 99 | 68-69 | Dr. Nicolas Guillaume |
DQA1*01:81 | 762103081025 | HLA33517 | Le Mene M, Villemonteix J, Jorge-Cordeiro D, Caillat-Zucman S | Characterization of the novel HLA-DQA1*01:81 allele by sequencing-based typing. | HLA | 2022 | 100 | 181-182 | Dr. Juliette Villemonteix |
DQA1*01:82 | 910835 | HLA33759 | Bost C, Cargou M, Fort M, Congy-Jolivet N, Bouthemy C | Identification of the novel HLA-DQA1*01:82 allele by next-generation sequencing. | HLA | 2022 | 100 | 183-184 | Dr. Charlene Bouthemy |
DQA1*01:82 | HG00050262 | HLA33759 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:83 | HG00031687 | HLA33950 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:84 | 211903449 | HLA33933 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*01:85 | HG00031617 | HLA34207 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:86 | 212111943 | HLA34049 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*01:87:01:01 | 22S128 | HLA34365 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*01:87:01:02 | 22213051 | HLA35959 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*01:88N | 41815019 | HLA34613 | - | - | - | - | - | - | Dr. Romain Ferru-Clement |
DQA1*01:89 | 211259170 | HLA34458 | Cargou M, Andreani M, Bianculli AG, Guidicelli G, Visentin J | Characterization of the novel HLA-DQA1*01:89 allele by sequencing-based typing. | HLA | 2022 | 100 | 661-662 | Dr. Jonathan Visentin |
DQA1*01:90 | HG00050142 | HLA35091 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:91 | HG00050143 | HLA35109 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:91 | HG00050747 | HLA35109 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:92 | HG00049892 | HLA34841 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:93 | HG00031303 | HLA35006 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:94 | HG00031937 | HLA35329 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:95 | HG00030100 | HLA35241 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:95 | HG00050373 | HLA35241 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:96 | HG00031610 | HLA34820 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:97 | HG00050066 | HLA35321 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:98 | AN18881098 | HLA35346 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*01:98 | HG00049899 | HLA35346 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:99 | 2203067RDD | HLA35303 | Shen M, Duffy BF, Jennemann JE, Parikh BA, Liu C | A novel HLA-DQA1*01 allele, HLA-DQA1*01:99, identified by next-generation sequencing. | HLA | 2022 | 100 | 662-664 | Dr. Chang Liu |
DQA1*01:100 | 5951384-259596 | HLA35115 | - | - | - | - | - | - | Dr. Neifi Hassan Saloum Deghaide |
DQA1*01:100 | 5989272-262769 | HLA35115 | - | - | - | - | - | - | Dr. Neifi Hassan Saloum Deghaide |
DQA1*01:101 | AMC-Q-E-001 | HLA36358 | - | - | - | - | - | - | Mrs. So-Jung Choi |
DQA1*01:102 | 22022708 | HLA36569 | - | - | - | - | - | - | Dr. Robert Bray |
DQA1*01:103 | HG00050498 | HLA36439 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:104 | 6000738-263974 | HLA36736 | - | - | - | - | - | - | Dr. Neifi Hassan Saloum Deghaide |
DQA1*01:105 | UHB0009 | HLA36700 | - | - | - | - | - | - | Mr. Marc Kleiser |
DQA1*01:106 | HILAPL-005 | HLA36769 | - | - | - | - | - | - | Dr. Qian Hu |
DQA1*01:106 | HG00029386 | HLA36769 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:107 | HILAPL-006 | HLA36771 | - | - | - | - | - | - | Dr. Qian Hu |
DQA1*01:108 | HG00050622 | HLA36813 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:109 | HG00050732 | HLA36861 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:110 | HG00050746 | HLA36873 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*01:111 | HG00050736 | HLA36898 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:01:01:01 | LG-10 | HLA00607 | Chang HC, Moriuchi T, Silver J | The heavy chain of human B-cell alloantigen HLA-DS has a variable N-terminal region and a constant immunoglobulin-like region | Nature | 1983 | 305 | 813-815 | Dr. Jack Silver |
DQA1*02:01:01:01 | BEI DM24 DM28 DM29 |
HLA00607 | Todd JA, Bell JI, McDevitt HO | HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus | Nature | 1987 | 329 | 599-604 | Dr. John A. Todd |
DQA1*02:01:01:01 | MOU | HLA00607 | Yasunaga S, Kimura A, Hamaguchi K, Ronningen KS, Sasazuki T | Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM) | Tissue Antigens | 1996 | 47 | 37-48 | Glyn Stacey |
DQA1*02:01:01:01 | DBB | HLA00607 | Horton R, Gibson R, Coggill P, Miretti M, Allcok RJ, Almeida J, Forbes S, Gilbert JGR, Halls K, Harrow JL, Hart E, Howe K, Jackson DK, Palmer S, Roberts AN, Sims S, Stewart CA, Traherne JA, Trevanion S, Wilming L, Rogers J, de Jong PJ, Elliott JF, Sawcer S, Todd JA, Trowsdale J, Beck S | Variation analysis and gene annotation of eight MHC haplotypes: The MHC Haplotype Project. | Immunogenetics | 2008 | 60 | 1-18 | Prof. Stephan Beck |
DQA1*02:01:01:01 | 1117029402 | HLA00607 | - | - | - | - | - | - | Mr. Gerald Bertrand |
DQA1*02:01:01:02 | BEL5GB | HLA14794 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*02:01:01:03 | 18-3100-CHP 18-4998-CHP |
HLA33695 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*02:01:01:04 | 18-4967-CHP | HLA33865 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*02:01:01:05 | 202210038 | HLA36341 | - | - | - | - | - | - | Dr. Amalia Tejeda Velarde |
DQA1*02:01:02 | IME 262-17 | HLA17070 | Galluccio T, Guagnano A, Stanglino G, Vicenza T, Andreani M | A new allele, HLA-DQA1*02:01:02 | HLA | 2017 | 90 | 376-377 | Dr. Mariarosa Battarra |
DQA1*02:01:03 | 111406213 | HLA26806 | - | - | - | - | - | - | Dr. Francesc Rudilla |
DQA1*02:01:03 | 111406213 | HLA26806 | - | - | - | - | - | - | Dr. Francesc Rudilla |
DQA1*02:01:03 | scu10026 | HLA26806 | - | - | - | - | - | - | Dr. Francisco de Paula Sanchez Gordo |
DQA1*02:01:04 | HG00027195 | HLA28564 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:01:05 | 19221997 | HLA30754 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*02:01:06 | 105630 | HLA30600 | - | - | - | - | - | - | Dr. Francisco de Paula Sanchez Gordo |
DQA1*02:01:07 | 211813934 | HLA33946 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*02:01:08 | 211801365 | HLA33896 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*02:01:09:01 | 22S129 | HLA34404 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*02:01:09:01 | 202118037 | HLA34404 | Gil-Etayo FJ, Torio A, Nino Ramirez JE, Jimenez Hernaz I, Tejeda Velarde A | Identification of the novel HLA-DQA1*02:01:09:01 allele by two different next-generation sequencing platforms. | HLA | 2023 | 101 | 80-82 | Dr. Amalia Tejeda Velarde |
DQA1*02:01:09:01 | 202203996 | HLA34404 | Gil-Etayo FJ, Torio A, Nino Ramirez JE, Jimenez Hernaz I, Tejeda Velarde A | Identification of the novel HLA-DQA1*02:01:09:01 allele by two different next-generation sequencing platforms. | HLA | 2023 | 101 | 80-82 | Dr. Amalia Tejeda Velarde |
DQA1*02:01:09:02 | 109224 | HLA35123 | - | - | - | - | - | - | Dr. Francisco de Paula Sanchez Gordo |
DQA1*02:01:10 | 41701059 | HLA34461 | - | - | - | - | - | - | Dr. Romain Ferru-Clement |
DQA1*02:01:11 | 39970 | HLA35230 | - | - | - | - | - | - | Dr. Michael Gautreaux |
DQA1*02:01:11 | JH0052 | HLA35230 | - | - | - | - | - | - | Dr. Maria Bettinotti |
DQA1*02:01:12 | HG00050335 | HLA35810 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:01:13 | HG00050428 | HLA36092 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:01:14 | 2210614495 | HLA36075 | - | - | - | - | - | - | Dr. Jonathan Visentin |
DQA1*02:01:15Q | VGh022 | HLA36440 | - | - | - | - | - | - | Dr. Jenny Tran |
DQA1*02:01:16 | A1013262 | HLA36640 | - | - | - | - | - | - | Ms. Ashley Drabik |
DQA1*02:02N | UA2018tp1343 | HLA19792 | - | - | - | - | - | - | Dr. Mats Bengtsson |
DQA1*02:03 | Ua2016tp1069 | HLA21917 | - | - | - | - | - | - | Dr. Mats Bengtsson |
DQA1*02:04 | HG00021562 | HLA24250 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:05 | HG00021570 | HLA24223 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:07 | Z42088 | HLA25026 | - | - | - | - | - | - | Miss. Sarah Blow |
DQA1*02:08 | HG00022548 HG00022549 |
HLA25299 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:09 | HG00024950 HG00024951 |
HLA25227 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:09 | HG00025331 | HLA25227 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:10 | HG00025054 | HLA24935 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:11 | HLA-UERJ-103177 | HLA26346 | Vianna R, Secco D, Santos A, Porto LC | Identification of the novel HLA-DQA1*02:11 allele in a Brazilian candidate donor for bone marrow donation | HLA | 2020 | 95 | 228-229 | Dr. Romulo Vianna |
DQA1*02:11 | HG00028875 | HLA26346 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:12 | 32944 | HLA26557 | Ingram KJ, O’Shields EF, Kiger D, Gautreaux MD | NGS and HLA: The long road ahead | Human Immunology | 2020 | 81 | 280-284 | Dr. Michael Gautreaux |
DQA1*02:12 | HG00028852 HG00028879 |
HLA26557 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:13 | 111402399 | HLA28581 | - | - | - | - | - | - | Dr. Francesc Rudilla |
DQA1*02:14 | 20211714 | HLA28681 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*02:15 | HG00028822 | HLA29492 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:16 | 762103033144 | HLA29511 | - | - | - | - | - | - | Dr. Juliette Villemonteix |
DQA1*02:16 | HG00028848 | HLA29511 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:17 | HLA032S009_Akt30 | HLA29790 | Zamanakou M, Vatsiou S, Stokidis S, Fortis SP, Germenis AE | Identification of two novel alleles, HLA-A*02:01:193 and -DQA1*02:17, in Greek individuals | HLA | 2021 | 97 | 521-523 | Prof. Anastasios Germenis |
DQA1*02:18 | HG00028850 | HLA30503 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:19 | 221012-68292-AJJI339 | HLA30919 | - | - | - | - | - | - | Dr. Hamid Liacini |
DQA1*02:19 | HG00029403 | HLA30919 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:20 | HG00029380 | HLA31338 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:21 | HG00029989 | HLA31674 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:22 | HG00029987 | HLA31604 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:23 | HG00029981 | HLA31665 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:23 | HG00030104 | HLA31665 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:23 | HG00031396 | HLA31665 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:23 | HG00030096 HG00030098 HG00031943 HG00031945 HG00031950 |
HLA31665 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:24 | HG00031619 | HLA33932 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:25 | 18-2959-CHP | HLA34165 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*02:26 | HG00049889 | HLA35172 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:27 | HG00050338 | HLA35773 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:28 | 24802779 | HLA36295 | - | - | - | - | - | - | Dr. Luis A. Marin |
DQA1*02:29 | HG00050422 | HLA36088 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:30 | HG00050503 | HLA36475 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*02:31 | HG00050735 | HLA36864 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:01:01:01 | NIN | HLA00608 | Horn GT, Bugawan TL, Long CM, Erlich HA | Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility | Proceedings of the National Academy of Sciences USA | 1988 | 85 | 6012-6016 | Dr. Henry Erlich |
DQA1*03:01:01:01 | BM.L DM24 DM29 |
HLA00608 | Todd JA, Bell JI, McDevitt HO | HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus | Nature | 1987 | 329 | 599-604 | Dr. John A. Todd |
DQA1*03:01:01:01 | JY | HLA00608 | Auffray C, Korman AJ, Roux-Dosseto M, Bono R, Strominger JL | cDNA clone for the heavy chain of the human B cell alloantigen DC1: strong sequence homology to the HLA-DR heavy chain | Proceedings of the National Academy of Sciences USA | 1982 | 79 | 6337-6341 | Prof. Jack L Strominger |
DQA1*03:01:01:01 | MMCC | HLA00608 | Horn GT, Bugawan TL, Long CM, Manos MM, Erlich HA | Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals | Human Immunology | 1988 | 21 | 249-263 | Dr. Henry Erlich |
DQA1*03:01:01:01 | BOLETH | HLA00608 | Jonsson AK, Hyldig-Nielsen JJ, Servenius B, Larhammar D, Andersson G, Jorgensen F, Peterson PA, Rask L | Class II genes of the human major histocompatibility complex. Comparisons of the DQ and DX alpha and beta genes | Journal of Biological Chemistry | 1987 | 262 | 8767-8777 | Dr. Goran Andersson |
DQA1*03:01:01:01 | BOLETH | HLA00608 | Yasunaga S, Kimura A, Hamaguchi K, Ronningen KS, Sasazuki T | Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM) | Tissue Antigens | 1996 | 47 | 37-48 | Glyn Stacey |
DQA1*03:01:01:01 | NA01960 | HLA00608 | Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S, Chang J, Palmieri A, Haugen E, Kaul R, Olson MV | Ancient haplotypes of the HLA Class II region | Genome Research | 2005 | 15 | 1250-1257 | Prof. Maynard Olson |
DQA1*03:01:01:01 | SSTO | HLA00608 | Horton R, Gibson R, Coggill P, Miretti M, Allcok RJ, Almeida J, Forbes S, Gilbert JGR, Halls K, Harrow JL, Hart E, Howe K, Jackson DK, Palmer S, Roberts AN, Sims S, Stewart CA, Traherne JA, Trevanion S, Wilming L, Rogers J, de Jong PJ, Elliott JF, Sawcer S, Todd JA, Trowsdale J, Beck S | Variation analysis and gene annotation of eight MHC haplotypes: The MHC Haplotype Project. | Immunogenetics | 2008 | 60 | 1-18 | Prof. Stephan Beck |
DQA1*03:01:01:01 | 215680 | HLA00608 | Witter K, Halliwell JA, Mautner J, Jolesch A, von Welser G, Rampp I, Spannagl M, Kauke T, Dick A | Group-specific amplification of HLA-DQA1 revealed a number of genomic full length sequences including the novel HLA alleles DQA1*01:10 and DQA1*01:11 | Tissue Antigens | 2014 | 83 | 49-51 | Dr. Klaus Witter |
DQA1*03:01:01:03 | 22-5083 | HLA36903 | - | - | - | - | - | - | Dr. M Rosa Moya-Quiles |
DQA1*03:01:03 | CE596 | HLA13330 | Balas A, Planelles D, García-Sánchez F, Prior C, Vicario JL | Three new HLA class II alleles: DRB1*08:70, DQA1*01:13 and DQA1*03:01:03 | International Journal of Immunogenetics | 2016 | 43 | 107-108 | Dr. Antonio Balas |
DQA1*03:01:04 | HG00021595 | HLA23654 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:01:05 | 1117018401 | HLA24036 | - | - | - | - | - | - | Mr. Gerald Bertrand |
DQA1*03:01:06 | 1910867187 | HLA26964 | Cargou M, Andreani M, Battarra M, Guidicelli G, Visentin J | Characterization of the novel HLA-DQA1*03:01:06 allele by sequencing-based typing | HLA | 2020 | 96 | 234-235 | Dr. Jonathan Visentin |
DQA1*03:01:07 | 21210269 | HLA31897 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*03:01:08 | 22S172 | HLA36208 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*03:01:09 | JH0048 | HLA36698 | - | - | - | - | - | - | Dr. Maria Bettinotti |
DQA1*03:01:09 | HG00028832 | HLA36698 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:01:09 | HG00050426 | HLA36698 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:02:01:01 | NA10540 | HLA00610 | Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S, Chang J, Palmieri A, Haugen E, Kaul R, Olson MV | Ancient haplotypes of the HLA Class II region | Genome Research | 2005 | 15 | 1250-1257 | Prof. Maynard Olson |
DQA1*03:02:01:01 | DKB | HLA00610 | Bell JI, Todd JA, McDevitt HO | The molecular basis of HLA-disease association | Advances in Human Genetics | 1989 | 18 | 1-41 | Prof. John Bell |
DQA1*03:02:01:01 | ISK | HLA00610 | Moriuchi J, Moriuchi T, Silver J | Nucleotide sequence of an HLA-DQ alpha chain derived from a DRw9 cell line: genetic and evolutionary implications | Proceedings of the National Academy of Sciences USA | 1985 | 82 | 3420-3424 | Dr. Jack Silver |
DQA1*03:02:01:01 | DKB | HLA00610 | Todd JA, Bell JI, McDevitt HO | HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus | Nature | 1987 | 329 | 599-604 | Dr. John A. Todd |
DQA1*03:02:01:01 | DKB | HLA00610 | Horn GT, Bugawan TL, Long CM, Erlich HA | Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility | Proceedings of the National Academy of Sciences USA | 1988 | 85 | 6012-6016 | Dr. Henry Erlich |
DQA1*03:02:01:01 | DKB | HLA00610 | Yasunaga S, Kimura A, Hamaguchi K, Ronningen KS, Sasazuki T | Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM) | Tissue Antigens | 1996 | 47 | 37-48 | Glyn Stacey |
DQA1*03:02:01:01 | 215443 | HLA00610 | Witter K, Halliwell JA, Mautner J, Jolesch A, von Welser G, Rampp I, Spannagl M, Kauke T, Dick A | Group-specific amplification of HLA-DQA1 revealed a number of genomic full length sequences including the novel HLA alleles DQA1*01:10 and DQA1*01:11 | Tissue Antigens | 2014 | 83 | 49-51 | Dr. Klaus Witter |
DQA1*03:02:01:01 | T106 | HLA00610 | Suzuki S, Ranade S, Osaki K, Iyo S, Shigenari A, Ohnuki Y, Oka A, Masuya A, Harting J, Baybayan P, Kitazume M, Sunaga J, Morishima S, Morishima Y, Inoko H, Kulski JK, Shiina T | Reference grade characterization of polymorphisms in full-length HLA class I and II genes with short-read sequencing on the ION PGM system and long-reads generated by single molecule, real-time sequencing on the PacBio platform | Frontiers in Immunology | 2018 | 9 | 2294- | Prof. Takashi Shiina |
DQA1*03:02:01:02 | T097 | HLA17309 | Suzuki S, Ranade S, Osaki K, Iyo S, Shigenari A, Ohnuki Y, Oka A, Masuya A, Harting J, Baybayan P, Kitazume M, Sunaga J, Morishima S, Morishima Y, Inoko H, Kulski JK, Shiina T | Reference grade characterization of polymorphisms in full-length HLA class I and II genes with short-read sequencing on the ION PGM system and long-reads generated by single molecule, real-time sequencing on the PacBio platform | Frontiers in Immunology | 2018 | 9 | 2294- | Prof. Takashi Shiina |
DQA1*03:02:01:02 | JM30 | HLA17309 | Suzuki S, Ranade S, Osaki K, Iyo S, Shigenari A, Ohnuki Y, Oka A, Masuya A, Harting J, Baybayan P, Kitazume M, Sunaga J, Morishima S, Morishima Y, Inoko H, Kulski JK, Shiina T | Reference grade characterization of polymorphisms in full-length HLA class I and II genes with short-read sequencing on the ION PGM system and long-reads generated by single molecule, real-time sequencing on the PacBio platform | Frontiers in Immunology | 2018 | 9 | 2294- | Prof. Takashi Shiina |
DQA1*03:02:01:02 | T7526 | HLA17309 | - | - | - | - | - | - | Dr. Mehdi Alizadeh |
DQA1*03:02:02 | AMC191120_HSH | HLA27804 | - | - | - | - | - | - | Dr. Oh-Joong Kwon |
DQA1*03:02:03 | TUJM323 | HLA31993 | - | - | - | - | - | - | Prof. Takashi Shiina |
DQA1*03:02:03 | YUNH006 | HLA31993 | Kim N, Hong JY, Jung S, Lee J, Park Y | Identification of the novel HLA-DQA1*03:02:03 allele using next-generation sequencing. | HLA | 2022 | 99 | 225-226 | Dr. Yoonhee Park |
DQA1*03:02:03 | HG00028841 HG00028843 |
HLA31993 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:02:03 | HG00029379 | HLA31993 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:02:04 | 41940176 | HLA34637 | - | - | - | - | - | - | Dr. Romain Ferru-Clement |
DQA1*03:03:01:01 | YT | HLA00611 | Yasunaga S, Kimura A, Hamaguchi K, Ronningen KS, Sasazuki T | Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM) | Tissue Antigens | 1996 | 47 | 37-48 | Dr. Shin'ichiro Yasunaga |
DQA1*03:03:01:01 | NA14661 | HLA00611 | Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S, Chang J, Palmieri A, Haugen E, Kaul R, Olson MV | Ancient haplotypes of the HLA Class II region | Genome Research | 2005 | 15 | 1250-1257 | Prof. Maynard Olson |
DQA1*03:03:01:01 | MLF | HLA00611 | Horton R, Gibson R, Coggill P, Miretti M, Allcok RJ, Almeida J, Forbes S, Gilbert JGR, Halls K, Harrow JL, Hart E, Howe K, Jackson DK, Palmer S, Roberts AN, Sims S, Stewart CA, Traherne JA, Trevanion S, Wilming L, Rogers J, de Jong PJ, Elliott JF, Sawcer S, Todd JA, Trowsdale J, Beck S | Variation analysis and gene annotation of eight MHC haplotypes: The MHC Haplotype Project. | Immunogenetics | 2008 | 60 | 1-18 | Prof. Stephan Beck |
DQA1*03:03:01:02 | BUR, E | HLA14795 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*03:03:01:03 | KE | HLA14797 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*03:03:01:03 | T331 | HLA14797 | Suzuki S, Ranade S, Osaki K, Iyo S, Shigenari A, Ohnuki Y, Oka A, Masuya A, Harting J, Baybayan P, Kitazume M, Sunaga J, Morishima S, Morishima Y, Inoko H, Kulski JK, Shiina T | Reference grade characterization of polymorphisms in full-length HLA class I and II genes with short-read sequencing on the ION PGM system and long-reads generated by single molecule, real-time sequencing on the PacBio platform | Frontiers in Immunology | 2018 | 9 | 2294- | Prof. Takashi Shiina |
DQA1*03:03:01:03 | JM06 | HLA14797 | Suzuki S, Ranade S, Osaki K, Iyo S, Shigenari A, Ohnuki Y, Oka A, Masuya A, Harting J, Baybayan P, Kitazume M, Sunaga J, Morishima S, Morishima Y, Inoko H, Kulski JK, Shiina T | Reference grade characterization of polymorphisms in full-length HLA class I and II genes with short-read sequencing on the ION PGM system and long-reads generated by single molecule, real-time sequencing on the PacBio platform | Frontiers in Immunology | 2018 | 9 | 2294- | Prof. Takashi Shiina |
DQA1*03:03:01:04 | AN73 | HLA19710 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*03:03:01:05 | LK707 | HLA21574 | Turner TR, Hayward DR, Gymer AW, Barker DJ, Leen G, Cambridge CA, Macpherson HL, Georgiou X, Cooper MA, Robinson J, Mayor NP, Marsh SGE | Widespread non-coding polymorphism in HLA class II genes of International HLA and Immunogenetics Workshop cell lines. | HLA | 2022 | 99 | 328-356 | Prof. Steven GE Marsh |
DQA1*03:03:01:06 | CB | HLA22307 | Turner TR, Hayward DR, Gymer AW, Barker DJ, Leen G, Cambridge CA, Macpherson HL, Georgiou X, Cooper MA, Robinson J, Mayor NP, Marsh SGE | Widespread non-coding polymorphism in HLA class II genes of International HLA and Immunogenetics Workshop cell lines. | HLA | 2022 | 99 | 328-356 | Prof. Steven GE Marsh |
DQA1*03:03:01:07 | KWO010 (KAPA) | HLA22343 | Turner TR, Hayward DR, Gymer AW, Barker DJ, Leen G, Cambridge CA, Macpherson HL, Georgiou X, Cooper MA, Robinson J, Mayor NP, Marsh SGE | Widespread non-coding polymorphism in HLA class II genes of International HLA and Immunogenetics Workshop cell lines. | HLA | 2022 | 99 | 328-356 | Prof. Steven GE Marsh |
DQA1*03:03:01:08 | HLA-UERJ-94593 | HLA25429 | Vianna R, Porto LC | Characterization of three novel HLA-DQA1*03:03:01 variants identified in Brazilian individuals | HLA | 2019 | 94 | 542-543 | Dr. Romulo Vianna |
DQA1*03:03:01:09 | HLA-UERJ-99391 | HLA24565 | Vianna R, Porto LC | Characterization of three novel HLA-DQA1*03:03:01 variants identified in Brazilian individuals | HLA | 2019 | 94 | 542-543 | Dr. Romulo Vianna |
DQA1*03:03:01:10 | HLA-UERJ-100666 | HLA24401 | Vianna R, Porto LC | Characterization of three novel HLA-DQA1*03:03:01 variants identified in Brazilian individuals | HLA | 2019 | 94 | 542-543 | Dr. Romulo Vianna |
DQA1*03:03:01:11 | HLA-UERJ-100680 | HLA25638 | Vianna R, Secco D, Santos A, Portp LC | Characterization of two novel HLA-DQA1*03:03:01 variants, identified in Brazilian individuals | HLA | 2020 | 95 | 583-584 | Dr. Romulo Vianna |
DQA1*03:03:01:12 | HLA-UERJ-103215 | HLA26509 | Vianna R, Secco D, Santos A, Portp LC | Characterization of two novel HLA-DQA1*03:03:01 variants, identified in Brazilian individuals | HLA | 2020 | 95 | 583-584 | Dr. Romulo Vianna |
DQA1*03:03:01:13 | HLA-UERJ-103260 | HLA26982 | Vianna R, Lopes G, Porto LC | Two novel HLA-DQA1*03:03:01 variants identified in Brazilian individuals: DQA1*03:03:01:13 and DQA1*03:03:01:14 | HLA | 2020 | 96 | 747-748 | Dr. Romulo Vianna |
DQA1*03:03:01:14 | HLA-UERJ-103617 | HLA28598 | Vianna R, Lopes G, Porto LC | Two novel HLA-DQA1*03:03:01 variants identified in Brazilian individuals: DQA1*03:03:01:13 and DQA1*03:03:01:14 | HLA | 2020 | 96 | 747-748 | Dr. Romulo Vianna |
DQA1*03:03:01:15 | HLA-UERJ-S51 | HLA29051 | Vianna R, Lopes G, Porto LC | Three novel HLA-DQA1 alleles identified in Brazilian individuals by next-generation sequencing | HLA | 2021 | 98 | 74-75 | Dr. Romulo Vianna |
DQA1*03:03:01:16Q | HT21-176985 | HLA31705 | CAsey H, Tyler J, Fisher C, Mowery C, Shike H | HLA-DQA1*03:03:01:16Q, a novel allele with a acceptor splice site mutation | HLA | 2021 | 98 | 490-492 | Dr. Hiroko Shike |
DQA1*03:03:01:17 | 18-4323-CHP 18-4332-CHP |
HLA34189 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*03:03:01:18 | A-3123D2 | HLA35578 | - | - | - | - | - | - | Dr. Meenakshi Singh |
DQA1*03:03:02 | 2208 | HLA07419 | Yan H, Liu X, Dong X, Li J, An P, Zhao L, Han F | Identification of three novel HLA-DQA1 alleles, DQA1*01:08, DQA1*01:09 and DQA1*03:03:02 | Tissue Antigens | 2012 | 80 | 551-553 | Prof. Fang Han |
DQA1*03:03:03 | 1117094931 | HLA24047 | - | - | - | - | - | - | Mr. Gerald Bertrand |
DQA1*03:03:04 | scu13318 | HLA30517 | - | - | - | - | - | - | Dr. Francisco de Paula Sanchez Gordo |
DQA1*03:03:05 | HG00026775 | HLA31099 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:03:05 | HLA-UERJ-104117 | HLA31099 | Vianna R, Lopes G, Secco D, Santos A, Porto LC | The novel HLA-DQA1 allele, HLA-DQA1*03:03:05, first described in a Brazilian individual | HLA | 2021 | 98 | 407-408 | Dr. Romulo Vianna |
DQA1*03:03:05 | HG00028892 | HLA31099 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:03:06 | HG00029409 | HLA31997 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:03:06 | HG00031728 HG00031729 HG00031730 |
HLA31997 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:03:07 | 18-5016-CHP | HLA33710 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*03:03:08 | HG00015336 | HLA36702 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:03:08 | UNICAMP588_09 | HLA36702 | - | - | - | - | - | - | Dr. Tania Kawasaki de Araujo |
DQA1*03:03:08 | HG00029979 HG00031491 |
HLA36702 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:03:09 | JH0049 | HLA36642 | - | - | - | - | - | - | Dr. Maria Bettinotti |
DQA1*03:03:09 | HG00028860 HG00028877 |
HLA36642 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:03:09 | HG00029396 | HLA36642 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:04 | 015940462 | HLA17290 | - | - | - | - | - | - | Miss. Sarah Colom |
DQA1*03:05 | HG00017437 | HLA20961 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:06 | 19203169 | HLA22724 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*03:07 | LKT14 | HLA22685 | Turner TR, Hayward DR, Gymer AW, Barker DJ, Leen G, Cambridge CA, Macpherson HL, Georgiou X, Cooper MA, Robinson J, Mayor NP, Marsh SGE | Widespread non-coding polymorphism in HLA class II genes of International HLA and Immunogenetics Workshop cell lines. | HLA | 2022 | 99 | 328-356 | Prof. Steven GE Marsh |
DQA1*03:08 | 31049 | HLA22820 | Ingram KJ, O’Shields EF, Kiger D, Gautreaux MD | NGS and HLA: The long road ahead | Human Immunology | 2020 | 81 | 280-284 | Dr. Michael Gautreaux |
DQA1*03:09 | Ua2019tp642 | HLA22908 | - | - | - | - | - | - | Dr. Mats Bengtsson |
DQA1*03:10 | UOU0001 UOU0002 UOU0003 UOU0004 |
HLA24211 | - | - | - | - | - | - | Dr. Eszter Lazar-Molnar |
DQA1*03:11 | 65172053676 | HLA25379 | Genebrier S, Lemal R, Texeraud E, Bertrand G, Renac V | Characterization of the novel HLA-DQA1*03:11 allele by next-generation sequencing | HLA | 2021 | 98 | 78-79 | Mr. Gerald Bertrand |
DQA1*03:12 | HG00024955 | HLA24374 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:13 | UOU0022 UOU0023 UOU0024 |
HLA26502 | - | - | - | - | - | - | Dr. Eszter Lazar-Molnar |
DQA1*03:13 | HG00031301 | HLA26502 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:14 | 19-10-16-ADN4Bes | HLA26487 | - | - | - | - | - | - | Dr. Mehdi Alizadeh |
DQA1*03:15 | 1910782167 | HLA26853 | Cargou M, Andreani M, Battarra M, Guidicelli G, Visentin J | Characterization of the novel HLA-DQA1*03:15 allele by sequencing-based typing | HLA | 2020 | 96 | 236-237 | Dr. Jonathan Visentin |
DQA1*03:16 | HG00026341 | HLA27216 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:17 | UOU0060 | HLA29192 | - | - | - | - | - | - | Dr. Eszter Lazar-Molnar |
DQA1*03:18 | 400487 | HLA29401 | - | - | - | - | - | - | Dr. Jinguo Wang |
DQA1*03:19 | HG00028825 HG00028831 |
HLA30219 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:19 | HG00028818 | HLA30219 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:19 | HG00030011 | HLA30219 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:20 | 2010994865 | HLA29890 | Cargou M, Andreani M, Bianculli AG, Blouin L, Visentin J | Characterization of the novel HLA-DQA1*03:20 allele by sequencing-based typing | HLA | 2021 | 98 | 492-494 | Dr. Jonathan Visentin |
DQA1*03:20 | HG00031490 | HLA29890 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:21 | 017932491 | HLA30850 | - | - | - | - | - | - | Mrs. Ornella Senoussi |
DQA1*03:22 | HG00029397 | HLA31098 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:22 | HG00031946 | HLA31098 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:22 | HG00050336 | HLA31098 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:22 | HG00050733 | HLA31098 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:23 | HG00029688 | HLA30960 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:23 | HG00029955 | HLA30960 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:24 | HG00029684 HG00029685 |
HLA30926 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:25 | HG00029992 | HLA31477 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:25 | HG00030123 | HLA31477 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:25 | HG00050140 | HLA31477 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:26 | HG00030105 | HLA31988 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:27N | HG00030102 | HLA32188 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:27N | HG00050252 | HLA32188 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:27N | HG00050259 | HLA32188 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:28 | 20220086 | HLA32571 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*03:29 | HG00031309 | HLA33154 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:30 | HG00031293 | HLA33121 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:31 | 24812756 | HLA34276 | Marin Rubio LA, Rada Martinez R, Ontanon Rodriguez J | Four novel HLA-Class II alleles: DQA1*03:31, DQB1*05:01:01:19, DPA1*02:01:01:20 and DPA1*02:01:01:28, characterized in Spanish individuals. | HLA | 2022 | 100 | 292-293 | Dr. Luis A. Marin |
DQA1*03:32N | HG00031307 | HLA35149 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:33 | HG00031941 | HLA35147 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:34N | HG00050151 | HLA34828 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:35 | HG00049888 | HLA34863 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:36 | HG00031306 | HLA34999 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:37 | HG00017075 | HLA35008 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:38 | HG00049896 | HLA35323 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:39 | HG00050251 | HLA35398 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:40 | 5957638-260980 | HLA36196 | - | - | - | - | - | - | Dr. Neifi Hassan Saloum Deghaide |
DQA1*03:41 | HG00050427 | HLA36109 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:42 | 5979641-262011 | HLA36516 | - | - | - | - | - | - | Dr. Neifi Hassan Saloum Deghaide |
DQA1*03:43 | HG00050502 | HLA36433 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*03:44 | 22218493 | HLA36930 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*04:01:01:01 | ARC | HLA00612 | Horn GT, Bugawan TL, Long CM, Erlich HA | Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility | Proceedings of the National Academy of Sciences USA | 1988 | 85 | 6012-6016 | Dr. Henry Erlich |
DQA1*04:01:01:01 | 2041 | HLA00612 | Hurley CK, Gregersen P, Steiner N, Bell J, Hartzman R, Nepom G, Silver J, Johnson AH | Polymorphism of the HLA-D region in American blacks. A DR3 haplotype generated by recombination | Journal of Immunology | 1988 | 140 | 885-892 | Prof. Carolyn K Hurley |
DQA1*04:01:01:01 | MADURA | HLA00612 | Todd JA, Bell JI, McDevitt HO | HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus | Nature | 1987 | 329 | 599-604 | Dr. John A. Todd |
DQA1*04:01:01:01 | BM9 | HLA00612 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*04:01:01:01 | BM9 | HLA00612 | Turner TR, Hayward DR, Gymer AW, Barker DJ, Leen G, Cambridge CA, Macpherson HL, Georgiou X, Cooper MA, Robinson J, Mayor NP, Marsh SGE | Widespread non-coding polymorphism in HLA class II genes of International HLA and Immunogenetics Workshop cell lines. | HLA | 2022 | 99 | 328-356 | Prof. Steven GE Marsh |
DQA1*04:01:01:02 | T131 | HLA17311 | Suzuki S, Ranade S, Osaki K, Iyo S, Shigenari A, Ohnuki Y, Oka A, Masuya A, Harting J, Baybayan P, Kitazume M, Sunaga J, Morishima S, Morishima Y, Inoko H, Kulski JK, Shiina T | Reference grade characterization of polymorphisms in full-length HLA class I and II genes with short-read sequencing on the ION PGM system and long-reads generated by single molecule, real-time sequencing on the PacBio platform | Frontiers in Immunology | 2018 | 9 | 2294- | Prof. Takashi Shiina |
DQA1*04:01:01:03 | T106 | HLA17312 | Suzuki S, Ranade S, Osaki K, Iyo S, Shigenari A, Ohnuki Y, Oka A, Masuya A, Harting J, Baybayan P, Kitazume M, Sunaga J, Morishima S, Morishima Y, Inoko H, Kulski JK, Shiina T | Reference grade characterization of polymorphisms in full-length HLA class I and II genes with short-read sequencing on the ION PGM system and long-reads generated by single molecule, real-time sequencing on the PacBio platform | Frontiers in Immunology | 2018 | 9 | 2294- | Prof. Takashi Shiina |
DQA1*04:01:01:04 | RSH | HLA17768 | - | - | - | - | - | - | Dr. Mehdi Alizadeh |
DQA1*04:01:01:05 | AN53 | HLA21954 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*04:01:01:06 | AN59 | HLA22536 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*04:01:01:07 | SPACH | HLA22379 | Jonsson AK, Andersson L, Rask L | Complete sequences of DQA1 and DQB1 cDNA clones corresponding to the DQw4 specificity | Immunogenetics | 1989 | 30 | 232-234 | Dr. Goran Andersson |
DQA1*04:01:01:07 | SPACH | HLA22379 | Yasunaga S, Kimura A, Hamaguchi K, Ronningen KS, Sasazuki T | Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM) | Tissue Antigens | 1996 | 47 | 37-48 | Prof. Akinori Kimura |
DQA1*04:01:01:07 | SPACH | HLA22379 | Turner TR, Hayward DR, Gymer AW, Barker DJ, Leen G, Cambridge CA, Macpherson HL, Georgiou X, Cooper MA, Robinson J, Mayor NP, Marsh SGE | Widespread non-coding polymorphism in HLA class II genes of International HLA and Immunogenetics Workshop cell lines. | HLA | 2022 | 99 | 328-356 | Prof. Steven GE Marsh |
DQA1*04:01:01:07 | GRC-150 | HLA22379 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*04:01:01:08 | DNA-76-NAT | HLA22766 | Alizadeh M, Picard C, Frassati C, Walencik A, Cesbron Gauthier A, Bennasar F, Verite F, Semana G | A new set of reagents and related software used for NGS based classical and non-classical HLA tying showing evidence for a greater HLA haplotype diversity | Human Immunology | 2020 | 81 | 202-205 | Dr. Mehdi Alizadeh |
DQA1*04:01:01:09 | HLA-UERJ-C2333 HLA-UERJ-102967 |
HLA26202 | Vianna R, Secco D, Santos A, Porto LC | Characterization and confirmation of the HLA-DQA1*04:01:01:09 allele, identified in a Brazilian individual | HLA | 2020 | 95 | 153-154 | Dr. Romulo Vianna |
DQA1*04:01:01:10 | HLA-UERJ-104403 | HLA33926 | - | - | - | - | - | - | Dr. Romulo Vianna |
DQA1*04:01:01:11 | 18-2983-CHP | HLA34208 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*04:01:02:01 | CDC120202 | HLA01694 | Cordovado SK, Hancock LN, Simone AE, Hendrix M, Mueller PW | High-resolution genotyping of HLA-DQA1 in the GoKinD study and identification of novel alleles HLA-DQA1*040102, HLA-DQA1*0402 and HLA-DQA1*0404 | Tissue Antigens | 2005 | 65 | 448-458 | Dr. Suzanne Cordovado |
DQA1*04:01:02:01 | 214940 | HLA01694 | Witter K, Halliwell JA, Mautner J, Jolesch A, von Welser G, Rampp I, Spannagl M, Kauke T, Dick A | Group-specific amplification of HLA-DQA1 revealed a number of genomic full length sequences including the novel HLA alleles DQA1*01:10 and DQA1*01:11 | Tissue Antigens | 2014 | 83 | 49-51 | Dr. Klaus Witter |
DQA1*04:01:02:02 | 215677 | HLA09342 | Witter K, Halliwell JA, Mautner J, Jolesch A, von Welser G, Rampp I, Spannagl M, Kauke T, Dick A | Group-specific amplification of HLA-DQA1 revealed a number of genomic full length sequences including the novel HLA alleles DQA1*01:10 and DQA1*01:11 | Tissue Antigens | 2014 | 83 | 49-51 | Dr. Klaus Witter |
DQA1*04:01:02:03 | 17-3456-CHP | HLA34197 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*04:01:02:04 | 18-4340-CHP | HLA34214 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*04:01:03 | HG00019404 | HLA22160 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*04:01:03 | HG00021581 | HLA22160 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*04:01:04 | HG00029398 | HLA31403 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*04:01:04 | HG00029978 HG00029980 |
HLA31403 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*04:01:04 | HG00030121 | HLA31403 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*04:01:04 | HG00030106 | HLA31403 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*04:01:04 | HG00031290 HG00031295 HG00031296 |
HLA31403 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*04:01:04 | HG00031394 | HLA31403 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*04:01:04 | HG00031615 | HLA31403 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*04:01:04 | HG00028835 HG00028836 HG00028837 HG00028838 HG00028840 HG00028845 HG00028859 HG00028862 HG00028865 HG00028873 HG00028882 HG00028885 HG00028886 |
HLA31403 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*04:01:04 | HG00031304 HG00031930 HG00031934 HG00031938 HG00031939 HG00031948 HG00049882 HG00049885 HG00050149 |
HLA31403 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*04:01:04 | HG00049881 | HLA31403 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*04:01:05 | HG00029977 | HLA31711 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*04:01:06 | 5937322-258720 | HLA34998 | - | - | - | - | - | - | Dr. Neifi Hassan Saloum Deghaide |
DQA1*04:01:07 | VGH021 | HLA36476 | - | - | - | - | - | - | Dr. Jenny Tran |
DQA1*04:01:08 | 6017740-266550 | HLA36604 | - | - | - | - | - | - | Dr. Neifi Hassan Saloum Deghaide |
DQA1*04:02 | CDC121802 | HLA01697 | Cordovado SK, Hancock LN, Simone AE, Hendrix M, Mueller PW | High-resolution genotyping of HLA-DQA1 in the GoKinD study and identification of novel alleles HLA-DQA1*040102, HLA-DQA1*0402 and HLA-DQA1*0404 | Tissue Antigens | 2005 | 65 | 448-458 | Dr. Suzanne Cordovado |
DQA1*04:02 | 218235 | HLA01697 | Witter K, Halliwell JA, Mautner J, Jolesch A, von Welser G, Rampp I, Spannagl M, Kauke T, Dick A | Group-specific amplification of HLA-DQA1 revealed a number of genomic full length sequences including the novel HLA alleles DQA1*01:10 and DQA1*01:11 | Tissue Antigens | 2014 | 83 | 49-51 | Dr. Klaus Witter |
DQA1*04:03N | 1242 | HLA01774 | Luo M, Cohen CR, Narayansingh MJ, Pan S, McKinnon L, Brunham RC, Plummer FA | Identification of a novel HLA-DQA1 null allele, DQA1*0403N, from an East African woman | Tissue Antigens | 2004 | 63 | 609-611 | Dr. Ma Luo |
DQA1*04:03N | 22298T0016 | HLA01774 | - | - | - | - | - | - | Ms. Sarah Peacock |
DQA1*04:04 | CDC021704 | HLA01874 | Cordovado SK, Hancock LN, Simone AE, Hendrix M, Mueller PW | High-resolution genotyping of HLA-DQA1 in the GoKinD study and identification of novel alleles HLA-DQA1*040102, HLA-DQA1*0402 and HLA-DQA1*0404 | Tissue Antigens | 2005 | 65 | 448-458 | Dr. Suzanne Cordovado |
DQA1*04:04 | 21010112 | HLA01874 | - | - | - | - | - | - | Dr. Lotte Wieten |
DQA1*04:05 | 4139456 | HLA19916 | Cargou M, Ralazamahaleo M, Blouin L, Guidicelli G, Visentin J | Characterization of the novel HLA-DQA1*04:05 allele by sequencing-based typing | HLA | 2019 | 93 | 59-60 | Dr. Jonathan Visentin |
DQA1*04:06 | HG00021586 | HLA23251 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*04:06 | HG00026340 | HLA23251 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*04:07 | SJHL18-653 | HLA24585 | - | - | - | - | - | - | Dr. Po-Chien Chou |
DQA1*04:07 | HG00028834 | HLA24585 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*04:08 | 1910542284 | HLA26363 | Cargou M, Andreani M, Testa G, Guidicelli G, Visentin J | Characterization of the novel HLA-DQA1*04:08 allele by sequencing-based typing | HLA | 2020 | 95 | 584-585 | Dr. Jonathan Visentin |
DQA1*04:09 | HG00029991 | HLA31634 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*04:10 | HG00030091 | HLA31978 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*04:11 | HG00031284 | HLA33479 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*04:12N | HG00031292 | HLA33042 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*04:12N | HG00031493 | HLA33042 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*04:13 | 109009 | HLA34661 | - | - | - | - | - | - | Dr. Francisco de Paula Sanchez Gordo |
DQA1*04:14N | VAUN_212643124 | HLA35531 | - | - | - | - | - | - | Dr. Gregory Gatouillat |
DQA1*04:15 | HG00050539 | HLA36469 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*04:16 | JH0051 | HLA36609 | - | - | - | - | - | - | Dr. Maria Bettinotti |
DQA1*04:17 | HG00050470 | HLA36822 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:01:01:01 | CMCC | HLA00613 | Horn GT, Bugawan TL, Long CM, Manos MM, Erlich HA | Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals | Human Immunology | 1988 | 21 | 249-263 | Dr. Henry Erlich |
DQA1*05:01:01:01 | RAJI | HLA00613 | Schenning L, Larhammar D, Bill P, Wiman K, Jonsson AK, Rask L, Peterson PA | Both alpha and beta chains of HLA-DC class II histocompatibility antigens display extensive polymorphism in their amino-terminal domains | EMBO Journal | 1984 | 3 | 447-452 | Dr. Goran Andersson |
DQA1*05:01:01:01 | HSF7 | HLA00613 | - | - | - | - | - | - | Prof. Stephan Beck |
DQA1*05:01:01:01 | QBL | HLA00613 | Traherne JA, Horton R, Roberts AN, Miretti MM, Hurles ME, Stewart CA, Ashurst JL, Atrazhev AM, Coggill P, Palmer S, Almeida J, Sims S, Wilming LG, Rogers J, de Jong PJ, Carrington M, Elliott JF, Sawcer S, Todd JA, Trowsdale J, Beck S | Genetic analysis of completely sequenced disease-associated MHC haplotypes identifies shuffling of segments in recent human history | PLoS Genetics | 2006 | 2 | 81-92 | Prof. Stephan Beck |
DQA1*05:01:01:01 | QBL | HLA00613 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*05:01:01:02 | VAVY | HLA06618 | Yasunaga S, Kimura A, Hamaguchi K, Ronningen KS, Sasazuki T | Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM) | Tissue Antigens | 1996 | 47 | 37-48 | Prof. Akinori Kimura |
DQA1*05:01:01:02 | NA01018 NA10923 |
HLA06618 | Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S, Chang J, Palmieri A, Haugen E, Kaul R, Olson MV | Ancient haplotypes of the HLA Class II region | Genome Research | 2005 | 15 | 1250-1257 | Prof. Maynard Olson |
DQA1*05:01:01:02 | COX | HLA06618 | Stewart CA, Horton R, Allcock RJ, Ashurst JL, Atrazhev AM, Coggill P, Dunham I, Forbes S, Halls K, Howson JM, Humphray SJ, Hunt S, Mungall AJ, Osoegawa K, Palmer S, Roberts AN, Rogers J, Sims S, Wang Y, Wilming LG, Elliott JF, de Jong PJ, Sawcer S, Todd JA, Trowsdale J, Beck S | Complete MHC haplotype sequencing for common disease gene mapping | Genome Research | 2004 | 14 | 1176-1187 | Prof. Stephan Beck |
DQA1*05:01:01:02 | VAVY BRO, LJ REE, GD |
HLA06618 | - | - | - | - | - | - | Dr. M. L. Ashdown |
DQA1*05:01:01:03 | CHA, AJ | HLA14799 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*05:01:01:04 | AN72 | HLA22731 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*05:01:01:05 | 18-4320-CHP | HLA33911 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*05:01:01:06 | 18-4885-CHP 18-4915-CHP 18-4919-CHP 18-4935-CHP 18-4938-CHP |
HLA33924 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*05:01:01:07 | 18-2985-CHP 18-4957-CHP |
HLA33868 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*05:01:01:08 | 71587567 | HLA36906 | - | - | - | - | - | - | Dr. Luis A. Marin |
DQA1*05:01:02 | MG3 | HLA00614 | Bell JI, Todd JA, McDevitt HO | The molecular basis of HLA-disease association | Advances in Human Genetics | 1989 | 18 | 1-41 | Prof. John Bell |
DQA1*05:01:02 | MG3 | HLA00614 | Todd JA, Bell JI, McDevitt HO | HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus | Nature | 1987 | 329 | 599-604 | Dr. John A. Todd |
DQA1*05:01:04 | 161001028901 | HLA18836 | - | - | - | - | - | - | Dr. Mehdi Alizadeh |
DQA1*05:01:05 | 93114937 | HLA21938 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*05:01:06 | 30755 | HLA22796 | Ingram KJ, O’Shields EF, Kiger D, Gautreaux MD | NGS and HLA: The long road ahead | Human Immunology | 2020 | 81 | 280-284 | Dr. Michael Gautreaux |
DQA1*05:01:07 | 2101208 | HLA32464 | Blandin L, Ralazamahaleo M, Guidicelli G, Rouzaire P, Lemal R | Characterization of the novel HLA-DQA1*05:01:07 allele by sequencing-based typing. | HLA | 2022 | 99 | 138-139 | Dr. Paul Rouzaire |
DQA1*05:01:07 | HG00028826 | HLA32464 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:01:07 | HG00031285 | HLA32464 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:01:08:01 | 22S142 | HLA34282 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*05:01:08:02 | 24812703 | HLA35079 | - | - | - | - | - | - | Dr. Luis A. Marin |
DQA1*05:01:09 | 22S148 | HLA34600 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*05:01:10 | HG00021567 | HLA35343 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:01:10 | 018131379 | HLA35343 | - | - | - | - | - | - | Mrs. Ornella Senoussi |
DQA1*05:01:10 | 5996594-263744 | HLA35343 | - | - | - | - | - | - | Dr. Neifi Hassan Saloum Deghaide |
DQA1*05:01:10 | HG00028846 | HLA35343 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:01:10 | HG00030112 HG00030117 |
HLA35343 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:01:10 | HG00050253 | HLA35343 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:01:10 | HG00050538 | HLA35343 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:01:10 | HG00050621 | HLA35343 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:01:10 | HG00050748 | HLA35343 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:01:11 | 24812211 | HLA36739 | - | - | - | - | - | - | Dr. Luis A. Marin |
DQA1*05:02 | EMA | HLA00616 | Zimmerman PA, Phadke PM, Lee A, Elson LH, Aruajo E, Guderian R, Nutman TB | Migration of a novel DQA1* allele (DQA1*0502) from African origin to North and South America | Human Immunology | 1995 | 42 | 233-240 | Dr. Peter Zimmerman |
DQA1*05:02 | 2017-1577 | HLA00616 | - | - | - | - | - | - | Dr. Mauro Castagnetta |
DQA1*05:03:01:01 | AMALA | HLA00617 | Yasunaga S, Kimura A, Hamaguchi K, Ronningen KS, Sasazuki T | Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM) | Tissue Antigens | 1996 | 47 | 37-48 | Prof. Akinori Kimura |
DQA1*05:03:01:01 | AMALA | HLA00617 | - | - | - | - | - | - | Dr. M. L. Ashdown |
DQA1*05:03:01:01 | 218958 | HLA00617 | Witter K, Halliwell JA, Mautner J, Jolesch A, von Welser G, Rampp I, Spannagl M, Kauke T, Dick A | Group-specific amplification of HLA-DQA1 revealed a number of genomic full length sequences including the novel HLA alleles DQA1*01:10 and DQA1*01:11 | Tissue Antigens | 2014 | 83 | 49-51 | Dr. Klaus Witter |
DQA1*05:03:01:01 | 225175 | HLA00617 | - | - | - | - | - | - | Dr. Klaus Witter |
DQA1*05:03:01:02 | T149 | HLA17360 | Suzuki S, Ranade S, Osaki K, Iyo S, Shigenari A, Ohnuki Y, Oka A, Masuya A, Harting J, Baybayan P, Kitazume M, Sunaga J, Morishima S, Morishima Y, Inoko H, Kulski JK, Shiina T | Reference grade characterization of polymorphisms in full-length HLA class I and II genes with short-read sequencing on the ION PGM system and long-reads generated by single molecule, real-time sequencing on the PacBio platform | Frontiers in Immunology | 2018 | 9 | 2294- | Prof. Takashi Shiina |
DQA1*05:03:02 | 6518081560 | HLA24281 | - | - | - | - | - | - | Mr. Gerald Bertrand |
DQA1*05:04 | YD-069 | HLA00618 | - | - | - | - | - | - | Dr. Warwick Greville |
DQA1*05:04 | AD-YM23 | HLA00618 | - | - | - | - | - | - | Dr. Susan Lester |
DQA1*05:05:01:01 | BM21 | HLA00619 | - | - | - | - | - | - | Dr. Toshihiko Kaneshige |
DQA1*05:05:01:01 | NA00576 | HLA00619 | Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S, Chang J, Palmieri A, Haugen E, Kaul R, Olson MV | Ancient haplotypes of the HLA Class II region | Genome Research | 2005 | 15 | 1250-1257 | Prof. Maynard Olson |
DQA1*05:05:01:01 | BM21 JBUSH |
HLA00619 | - | - | - | - | - | - | Dr. M. L. Ashdown |
DQA1*05:05:01:02 | NA14661 | HLA06614 | Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S, Chang J, Palmieri A, Haugen E, Kaul R, Olson MV | Ancient haplotypes of the HLA Class II region | Genome Research | 2005 | 15 | 1250-1257 | Prof. Maynard Olson |
DQA1*05:05:01:02 | 214940 | HLA06614 | Witter K, Halliwell JA, Mautner J, Jolesch A, von Welser G, Rampp I, Spannagl M, Kauke T, Dick A | Group-specific amplification of HLA-DQA1 revealed a number of genomic full length sequences including the novel HLA alleles DQA1*01:10 and DQA1*01:11 | Tissue Antigens | 2014 | 83 | 49-51 | Dr. Klaus Witter |
DQA1*05:05:01:03 | RML | HLA06609 | Liu CP, Bach FH, Wu SK | Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes | Journal of Immunology | 1988 | 140 | 3631-3639 | Professor Shaokee Wu |
DQA1*05:05:01:03 | NA04535 | HLA06609 | Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S, Chang J, Palmieri A, Haugen E, Kaul R, Olson MV | Ancient haplotypes of the HLA Class II region | Genome Research | 2005 | 15 | 1250-1257 | Prof. Maynard Olson |
DQA1*05:05:01:03 | T119 | HLA06609 | Suzuki S, Ranade S, Osaki K, Iyo S, Shigenari A, Ohnuki Y, Oka A, Masuya A, Harting J, Baybayan P, Kitazume M, Sunaga J, Morishima S, Morishima Y, Inoko H, Kulski JK, Shiina T | Reference grade characterization of polymorphisms in full-length HLA class I and II genes with short-read sequencing on the ION PGM system and long-reads generated by single molecule, real-time sequencing on the PacBio platform | Frontiers in Immunology | 2018 | 9 | 2294- | Prof. Takashi Shiina |
DQA1*05:05:01:04 | MYE 2003 | HLA14801 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*05:05:01:05 | BUR, E | HLA14805 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*05:05:01:06 | GRC-138 | HLA14849 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*05:05:01:07 | BEL7MON | HLA15562 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*05:05:01:08 | C047 | HLA15563 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*05:05:01:09 | JM45 | HLA17361 | Suzuki S, Ranade S, Osaki K, Iyo S, Shigenari A, Ohnuki Y, Oka A, Masuya A, Harting J, Baybayan P, Kitazume M, Sunaga J, Morishima S, Morishima Y, Inoko H, Kulski JK, Shiina T | Reference grade characterization of polymorphisms in full-length HLA class I and II genes with short-read sequencing on the ION PGM system and long-reads generated by single molecule, real-time sequencing on the PacBio platform | Frontiers in Immunology | 2018 | 9 | 2294- | Prof. Takashi Shiina |
DQA1*05:05:01:10 | T119 | HLA17362 | Suzuki S, Ranade S, Osaki K, Iyo S, Shigenari A, Ohnuki Y, Oka A, Masuya A, Harting J, Baybayan P, Kitazume M, Sunaga J, Morishima S, Morishima Y, Inoko H, Kulski JK, Shiina T | Reference grade characterization of polymorphisms in full-length HLA class I and II genes with short-read sequencing on the ION PGM system and long-reads generated by single molecule, real-time sequencing on the PacBio platform | Frontiers in Immunology | 2018 | 9 | 2294- | Prof. Takashi Shiina |
DQA1*05:05:01:11 | AN39 | HLA19651 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*05:05:01:12 | SWEIG007 | HLA19774 | Horn GT, Bugawan TL, Long CM, Erlich HA | Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility | Proceedings of the National Academy of Sciences USA | 1988 | 85 | 6012-6016 | Dr. Henry Erlich |
DQA1*05:05:01:12 | SWEIG007 | HLA19774 | Turner TR, Hayward DR, Gymer AW, Barker DJ, Leen G, Cambridge CA, Macpherson HL, Georgiou X, Cooper MA, Robinson J, Mayor NP, Marsh SGE | Widespread non-coding polymorphism in HLA class II genes of International HLA and Immunogenetics Workshop cell lines. | HLA | 2022 | 99 | 328-356 | Prof. Steven GE Marsh |
DQA1*05:05:01:13 | MYE 2004 | HLA21782 | Turner TR, Hayward DR, Gymer AW, Barker DJ, Leen G, Cambridge CA, Macpherson HL, Georgiou X, Cooper MA, Robinson J, Mayor NP, Marsh SGE | Widespread non-coding polymorphism in HLA class II genes of International HLA and Immunogenetics Workshop cell lines. | HLA | 2022 | 99 | 328-356 | Prof. Steven GE Marsh |
DQA1*05:05:01:14 | DRH001 | HLA21939 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*05:05:01:15 | BM16 | HLA22297 | Yasunaga S, Kimura A, Hamaguchi K, Ronningen KS, Sasazuki T | Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM) | Tissue Antigens | 1996 | 47 | 37-48 | Prof. Akinori Kimura |
DQA1*05:05:01:15 | BM16 MOLT-4 |
HLA22297 | Turner TR, Hayward DR, Gymer AW, Barker DJ, Leen G, Cambridge CA, Macpherson HL, Georgiou X, Cooper MA, Robinson J, Mayor NP, Marsh SGE | Widespread non-coding polymorphism in HLA class II genes of International HLA and Immunogenetics Workshop cell lines. | HLA | 2022 | 99 | 328-356 | Prof. Steven GE Marsh |
DQA1*05:05:01:16 | HAG | HLA22537 | Turner TR, Hayward DR, Gymer AW, Barker DJ, Leen G, Cambridge CA, Macpherson HL, Georgiou X, Cooper MA, Robinson J, Mayor NP, Marsh SGE | Widespread non-coding polymorphism in HLA class II genes of International HLA and Immunogenetics Workshop cell lines. | HLA | 2022 | 99 | 328-356 | Prof. Steven GE Marsh |
DQA1*05:05:01:17 | AN32 | HLA22651 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*05:05:01:18 | AN33 | HLA22617 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*05:05:01:19 | BM15 | HLA22296 | Turner TR, Hayward DR, Gymer AW, Barker DJ, Leen G, Cambridge CA, Macpherson HL, Georgiou X, Cooper MA, Robinson J, Mayor NP, Marsh SGE | Widespread non-coding polymorphism in HLA class II genes of International HLA and Immunogenetics Workshop cell lines. | HLA | 2022 | 99 | 328-356 | Prof. Steven GE Marsh |
DQA1*05:05:01:20 | DAN723 | HLA22679 | Turner TR, Hayward DR, Gymer AW, Barker DJ, Leen G, Cambridge CA, Macpherson HL, Georgiou X, Cooper MA, Robinson J, Mayor NP, Marsh SGE | Widespread non-coding polymorphism in HLA class II genes of International HLA and Immunogenetics Workshop cell lines. | HLA | 2022 | 99 | 328-356 | Prof. Steven GE Marsh |
DQA1*05:05:01:21 | AN300206 | HLA22960 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*05:05:01:22 | HLA-UERJ-C2335 | HLA24979 | Vianna R, Secco D, Santos A, Porto LC | Characterization of two novel HLA-DQA1*05:05:01 variants, identified in Brazilian individuals | HLA | 2020 | 95 | 75-76 | Dr. Romulo Vianna |
DQA1*05:05:01:23 | HLA-UERJ-C2409 | HLA25859 | Vianna R, Secco D, Santos A, Porto LC | Characterization of two novel HLA-DQA1*05:05:01 variants, identified in Brazilian individuals | HLA | 2020 | 95 | 75-76 | Dr. Romulo Vianna |
DQA1*05:05:01:24 | HLA-UERJ-103097 | HLA26088 | Vianna R, Secco D, Santos A, Porto LC | Characterization of two novel HLA-DQA1*05:05:01 variants, identified in Brazilian individuals | HLA | 2020 | 95 | 230-231 | Dr. Romulo Vianna |
DQA1*05:05:01:25 | HLA-UERJ-103162 | HLA26378 | Vianna R, Secco D, Santos A, Porto LC | Characterization of two novel HLA-DQA1*05:05:01 variants, identified in Brazilian individuals | HLA | 2020 | 95 | 230-231 | Dr. Romulo Vianna |
DQA1*05:05:01:26 | HLA-UERJ-S45 | HLA29355 | Vianna R, Lopes G, Porto LC | Three novel HLA-DQA1 alleles identified in Brazilian individuals by next-generation sequencing | HLA | 2021 | 98 | 74-75 | Dr. Romulo Vianna |
DQA1*05:05:01:27 | 18-4996-CHP | HLA33821 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*05:05:01:28 | 18-3056-CHP 18-4997-CHP |
HLA33711 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*05:05:01:29 | 18-2981-CHP 18-3115-CHP 18-4302-CHP 18-4887-CHP 18-4910-CHP |
HLA33835 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*05:05:01:30 | 18-4346-CHP 18-4373-CHP 18-4374-CHP 18-4941-CHP 18-5065-CHP |
HLA33834 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*05:05:01:31 | 18-4886-CHP | HLA33901 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*05:05:01:32 | 18-3095-CHP 18-3101-CHP |
HLA33887 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*05:05:01:33 | 18-4935-CHP 18-4982-CHP |
HLA34087 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*05:05:01:34 | 18-2797-CHP 18-4985-CHP |
HLA34097 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*05:05:01:35 | 18-2984-CHP 18-3087-CHP 18-4281-CHP 18-4321-CHP 18-5022-CHP |
HLA34098 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*05:05:01:36 | 18-4300-CHP 18-4350-CHP |
HLA34164 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*05:05:01:37 | 18-3137-CHP 18-4904-CHP |
HLA34095 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*05:05:01:38 | HLA-UERJ-104399 | HLA34323 | - | - | - | - | - | - | Dr. Romulo Vianna |
DQA1*05:05:02 | 1118045001 | HLA24020 | - | - | - | - | - | - | Mr. Gerald Bertrand |
DQA1*05:05:03 | 19208513 | HLA25180 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*05:05:04 | 19214251 | HLA26186 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*05:05:05 | 1910913540 | HLA26965 | Cargou M, Andreani M, Giustiniani P, Blouin L, Visentin J | Characterization of the novel HLA-DQA1*05:05:05 allele by sequencing-based typing | HLA | 2020 | 96 | 372-373 | Dr. Jonathan Visentin |
DQA1*05:05:05 | 19225435 | HLA26965 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*05:05:05 | 34431 | HLA26965 | - | - | - | - | - | - | Dr. Michael Gautreaux |
DQA1*05:05:05 | HG00029411 | HLA26965 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:05:06 | 017385504 | HLA29267 | - | - | - | - | - | - | Mrs. Ornella Senoussi |
DQA1*05:05:07 | 018007767 | HLA30812 | - | - | - | - | - | - | Mrs. Ornella Senoussi |
DQA1*05:05:08 | HG00026345 | HLA31246 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:05:08 | 20226837 | HLA31246 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*05:05:08 | 76841091AN | HLA31246 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*05:05:08 | HG00029391 HG00030008 |
HLA31246 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:05:08 | HG00029956 | HLA31246 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:05:09 | HG00029399 | HLA31857 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:05:10 | 323941 | HLA33788 | Bradshaw R, Dunn P | The novel allele HLA-DQA1*05:05:10 was detected in a Nigerian who also lacks the DRB5 gene in the DRB1*16 haplotype. | HLA | 2022 | 99 | 667-668 | Mr. Robert Bradshaw |
DQA1*05:05:11 | 211900384 | HLA33916 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*05:05:11 | HG00031488 | HLA33916 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:05:12:01 | 211702470 | HLA34022 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*05:05:12:01 | 212102238 | HLA34022 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*05:05:12:02 | 41644017 | HLA34650 | - | - | - | - | - | - | Dr. Romain Ferru-Clement |
DQA1*05:05:13 | 211803379 | HLA34377 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*05:05:14 | 22S127 | HLA34399 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*05:05:14 | 2210227621 | HLA34399 | - | - | - | - | - | - | Dr. Jonathan Visentin |
DQA1*05:05:15 | 42140006 | HLA34568 | - | - | - | - | - | - | Dr. Romain Ferru-Clement |
DQA1*05:05:16:01 | VGH017 | HLA36515 | - | - | - | - | - | - | Dr. Jenny Tran |
DQA1*05:05:16:02 | VGH018 | HLA36886 | - | - | - | - | - | - | Dr. Jenny Tran |
DQA1*05:05:17 | 5968527-261320 | HLA36756 | - | - | - | - | - | - | Dr. Neifi Hassan Saloum Deghaide |
DQA1*05:06:01:01 | BM3114 | HLA02339 | Lee KW, Jung YA, Oh DH | Four novel human leukocyte antigen-DQA1 alleles identified in the Korean population | Tissue Antigens | 2006 | 68 | 167-172 | Dr. Kyung Wha Lee |
DQA1*05:06:01:01 | JM21 | HLA02339 | Suzuki S, Ranade S, Osaki K, Iyo S, Shigenari A, Ohnuki Y, Oka A, Masuya A, Harting J, Baybayan P, Kitazume M, Sunaga J, Morishima S, Morishima Y, Inoko H, Kulski JK, Shiina T | Reference grade characterization of polymorphisms in full-length HLA class I and II genes with short-read sequencing on the ION PGM system and long-reads generated by single molecule, real-time sequencing on the PacBio platform | Frontiers in Immunology | 2018 | 9 | 2294- | Prof. Takashi Shiina |
DQA1*05:06:01:02 | JM38 | HLA17363 | Suzuki S, Ranade S, Osaki K, Iyo S, Shigenari A, Ohnuki Y, Oka A, Masuya A, Harting J, Baybayan P, Kitazume M, Sunaga J, Morishima S, Morishima Y, Inoko H, Kulski JK, Shiina T | Reference grade characterization of polymorphisms in full-length HLA class I and II genes with short-read sequencing on the ION PGM system and long-reads generated by single molecule, real-time sequencing on the PacBio platform | Frontiers in Immunology | 2018 | 9 | 2294- | Prof. Takashi Shiina |
DQA1*05:06:01:03 | NATL11 | HLA28653 | - | - | - | - | - | - | Prof. Takashi Shiina |
DQA1*05:07 | BM3189 | HLA02340 | Lee KW, Jung YA, Oh DH | Four novel human leukocyte antigen-DQA1 alleles identified in the Korean population | Tissue Antigens | 2006 | 68 | 167-172 | Dr. Kyung Wha Lee |
DQA1*05:07 | JM36 | HLA02340 | Suzuki S, Ranade S, Osaki K, Iyo S, Shigenari A, Ohnuki Y, Oka A, Masuya A, Harting J, Baybayan P, Kitazume M, Sunaga J, Morishima S, Morishima Y, Inoko H, Kulski JK, Shiina T | Reference grade characterization of polymorphisms in full-length HLA class I and II genes with short-read sequencing on the ION PGM system and long-reads generated by single molecule, real-time sequencing on the PacBio platform | Frontiers in Immunology | 2018 | 9 | 2294- | Prof. Takashi Shiina |
DQA1*05:08 | BM3146 | HLA02341 | Lee KW, Jung YA, Oh DH | Four novel human leukocyte antigen-DQA1 alleles identified in the Korean population | Tissue Antigens | 2006 | 68 | 167-172 | Dr. Kyung Wha Lee |
DQA1*05:08 | 018181562 | HLA02341 | - | - | - | - | - | - | Mrs. Ornella Senoussi |
DQA1*05:09:01:01 | 218 20700 28137 |
HLA02433 | Voorter CEM, van den Berg-Loonen EM | Sequence-based typing of the complete coding sequence of DQA1 and phenotype frequencies in the Dutch Caucasian population | Human Immunology | 2006 | 67 | 756-763 | Prof. Ella M. Van den Berg-Loonen |
DQA1*05:09:01:01 | FH67 | HLA02433 | - | - | - | - | - | - | Mr. Konstantinos Barsakis |
DQA1*05:09:01:02 | 0009TL098222-T-124-504-713 | HLA33793 | - | - | - | - | - | - | Dr. Yoginder Pal Singh |
DQA1*05:10 | CTM-8005076 | HLA04360 | Balas A, García-Sánchez F, Vicario JL | A new DQA1 allele (DQA1*0510) in a Spanish Celiac disease patient | Tissue Antigens | 2010 | 75 | 287-288 | Dr. Antonio Balas |
DQA1*05:10 | 111411583 | HLA04360 | - | - | - | - | - | - | Dr. Francesc Rudilla |
DQA1*05:10 | 0201902966 | HLA04360 | - | - | - | - | - | - | Mrs. Silvia Ulrich |
DQA1*05:11:01:01 | NA01960 | HLA06617 | Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S, Chang J, Palmieri A, Haugen E, Kaul R, Olson MV | Ancient haplotypes of the HLA Class II region | Genome Research | 2005 | 15 | 1250-1257 | Prof. Maynard Olson |
DQA1*05:11:01:01 | NA01960 | HLA06617 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*05:11:01:02 | 18-3145-CHP 18-5083-CHP |
HLA34199 | - | - | - | - | - | - | Dr. Dimitri Monos |
DQA1*05:12 | HG00015334 | HLA20644 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:13 | 29860 | HLA21879 | Ingram KJ, Merkens H, O’Shields EF, Kiger D, Gautreaux MD | New HLA alleles discovered by NGS in routine lab work in a medium-volume HLA laboratory | Human Immunology | 2019 | 80 | 465-467 | Dr. Michael Gautreaux |
DQA1*05:13 | 1118047452 | HLA21879 | Genebrier S, Lemal R, Nivet C, Chérel M, Renac V | Characterization of the novel HLA-DQA1*05:13 allele by next-generation sequencing | HLA | 2021 | 98 | 241-243 | Mr. Gerald Bertrand |
DQA1*05:14 | 4246329 | HLA21694 | Cargou M, Andreani M, Troiano M, Guidicelli G, Visentin J | Characterization of the novel HLA-DQA1*05:14 allele by sequencing-based typing | HLA | 2019 | 93 | 241-243 | Dr. Jonathan Visentin |
DQA1*05:15N | HG00015338 | HLA22459 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:16 | HG00021561 | HLA23949 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:17N | HG00021568 | HLA23999 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:18 | 65162009487 | HLA23987 | Genebrier S, Rouzaire P, Texeraud E, Bertrand G, Renac V | Characterization of the novel HLA-DQA1*05:18 allele by next-generation sequencing | HLA | 2021 | 98 | 494-496 | Mr. Gerald Bertrand |
DQA1*05:19 | 65182020587 | HLA24139 | Genebrier S, Rouzaire P, Texeraud E, Betrand G, Renac V | Characterization of the novel HLA-DQA1*05:19 allele by next-generation sequencing | HLA | 2021 | 98 | 243-244 | Mr. Gerald Bertrand |
DQA1*05:20 | 19047848 | HLA24586 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*05:21 | HG00025450 | HLA24992 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:21 | 24963 | HLA24992 | Ingram KJ, O’Shields EF, Kiger D, Gautreaux MD | NGS and HLA: The long road ahead | Human Immunology | 2020 | 81 | 280-284 | Dr. Michael Gautreaux |
DQA1*05:22 | HG00025447 | HLA25777 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:23 | 1910262934 | HLA26247 | Cargou M, Andreani M, Diluzio A, Guidicelli G, Visentin J | Characterization of the novel HLA-DQA1*05:23 allele by sequencing-based typing | HLA | 2020 | 96 | 120-121 | Dr. Jonathan Visentin |
DQA1*05:24 | UOU0019 | HLA26735 | - | - | - | - | - | - | Dr. Eszter Lazar-Molnar |
DQA1*05:25 | 33342 | HLA26799 | Ingram KJ, O'Shields EF, Kiger DF, Netherton EM, Gautreaux MD | Identification of novel HLA alleles discovered in 2019-2021 | Human Immunology | 2021 | 82 | 982-984 | Dr. Michael Gautreaux |
DQA1*05:25 | 017298075 | HLA26799 | - | - | - | - | - | - | Mrs. Ornella Senoussi |
DQA1*05:25 | HG00029402 | HLA26799 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:26 | HG00027196 | HLA28565 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:26 | HG00028819 | HLA28565 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:27 | 111398990 | HLA28669 | - | - | - | - | - | - | Dr. Francesc Rudilla |
DQA1*05:28 | UHB0004 | HLA28695 | - | - | - | - | - | - | Mr. Marc Kleiser |
DQA1*05:28 | HG00028824 | HLA28695 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:29Q | 190500660401 | HLA28824 | - | - | - | - | - | - | Dr. Erik Rozemuller |
DQA1*05:30 | HG00028851 HG00028853 |
HLA29624 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:31 | PATJ0002 | HLA29787 | - | - | - | - | - | - | Mrs. Amandasue Landi |
DQA1*05:32 | HG00028856 | HLA30391 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:32 | HG00031286 | HLA30391 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:33 | 21206019 | HLA30247 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*05:33 | HG00028839 HG00028863 HG00028888 HG00028889 HG00028890 |
HLA30247 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:33 | HG00029385 | HLA30247 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:33 | HG00029985 | HLA30247 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:33 | HG00029982 HG00029983 HG00029984 |
HLA30247 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:33 | HG00030118 HG00030119 HG00030120 |
HLA30247 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:33 | HG00031299 | HLA30247 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:33 | HG00031397 HG00031398 |
HLA30247 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:33 | HG00031952 HG00031953 HG00049894 HG00049895 HG00050147 |
HLA30247 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:33 | HG00050148 | HLA30247 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:34 | HG00028874 | HLA30281 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:35:01 | HG00028893 | HLA30485 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:35:02 | 211801101 | HLA33938 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*05:36N | 20224856 | HLA29903 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*05:37 | HG00028849 | HLA30644 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:38 | scu13651 | HLA30511 | - | - | - | - | - | - | Dr. Francisco de Paula Sanchez Gordo |
DQA1*05:39 | HG00029407 | HLA30952 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:40 | HG00029393 | HLA31274 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:41 | HG00029683 | HLA31823 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:42 | HG00029988 | HLA31646 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:42 | HG00050144 | HLA31646 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:42 | HG00050467 | HLA31646 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:43 | HG00029986 | HLA31590 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:43 | HG00030122 | HLA31590 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:43 | HG00050620 | HLA31590 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:44 | HG00029996 | HLA31587 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:45 | HG00029998 | HLA31584 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:46 | HG00030092 | HLA32040 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:46 | HG00050468 | HLA32040 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:47 | 018072194 | HLA32173 | - | - | - | - | - | - | Mrs. Ornella Senoussi |
DQA1*05:48 | scu09701 | HLA32237 | - | - | - | - | - | - | Dr. Francisco de Paula Sanchez Gordo |
DQA1*05:49 | 2110464655 | HLA32389 | Cargou M, Andreani M, Galluccio T, Ralazamahaleo M, Visentin J | Characterization of the novel HLA-DQA1*05:49 allele by sequencing-based typing. | HLA | 2022 | 99 | 140-141 | Dr. Jonathan Visentin |
DQA1*05:50 | HG00031297 | HLA33124 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:50 | HG00031940 | HLA33124 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:51 | NRCH00010 | HLA32907 | Leonov EA, Abdrakhimova AR, Khizhinskiy SP, Khamaganova EG, Parovichnikova EN | Characterization of four new HLA alleles: HLA-A*68:288, -C*07:1012, -C*13:364, and -DQA1*05:51. | HLA | 2022 | 100 | 519-520 | Mr. Evgeny Leonov |
DQA1*05:51 | HG00031393 | HLA32907 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:52 | HG00031494 | HLA33963 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:52 | HG00031765 HG00031955 HG00050067 |
HLA33963 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:53 | 2111050533 | HLA33860 | Cargou M, Andreani M, Troiano M, Ralazamahaleo M, Visentin J | Characterization of the novel HLA-DQA1*05:53 allele by sequencing-based typing. | HLA | 2022 | 100 | 396-397 | Dr. Jonathan Visentin |
DQA1*05:54Q | KS1480_21 | HLA34105 | - | - | - | - | - | - | Dr. Marie Schaffer |
DQA1*05:55 | 212013756 | HLA34367 | - | - | - | - | - | - | Dr. Alexandre Walencik |
DQA1*05:56 | 21205276 | HLA34278 | - | - | - | - | - | - | Dr. Daniel Fuerst |
DQA1*05:57 | 42001068 | HLA34509 | - | - | - | - | - | - | Dr. Romain Ferru-Clement |
DQA1*05:58 | 42038003 | HLA34569 | - | - | - | - | - | - | Dr. Romain Ferru-Clement |
DQA1*05:59 | 018140432 | HLA34793 | - | - | - | - | - | - | Mrs. Ornella Senoussi |
DQA1*05:60 | HG00050146 | HLA35064 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:61 | HG00028827 HG00031608 HG00049883 HG00050145 |
HLA35286 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:61 | HG00050249 | HLA35286 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:62 | HG00021591 | HLA35315 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:63 | HG00031947 | HLA34868 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:64 | HG00030099 | HLA35373 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:65:01:01 | MAIGAB_220483499 | HLA35389 | - | - | - | - | - | - | Dr. Gregory Gatouillat |
DQA1*05:65:01:02 | 5993120-263426 | HLA36651 | - | - | - | - | - | - | Dr. Neifi Hassan Saloum Deghaide |
DQA1*05:66 | HG00050261 | HLA35407 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:67 | HG00050339 | HLA35766 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:68 | HG00050334 | HLA35909 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:69 | HG00050332 | HLA35753 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*05:70 | 5945228-259122 | HLA36135 | - | - | - | - | - | - | Dr. Neifi Hassan Saloum Deghaide |
DQA1*05:71 | 202209256 | HLA36663 | - | - | - | - | - | - | Dr. Amalia Tejeda Velarde |
DQA1*05:72 | 5988310-262749 | HLA36743 | - | - | - | - | - | - | Dr. Neifi Hassan Saloum Deghaide |
DQA1*05:73 | 202213078 | HLA36757 | - | - | - | - | - | - | Dr. Amalia Tejeda Velarde |
DQA1*05:74 | HILAPL_007 | HLA36909 | - | - | - | - | - | - | Dr. Qian Hu |
DQA1*06:01:01:01 | 202439 | HLA00620 | Witter K, Halliwell JA, Mautner J, Jolesch A, von Welser G, Rampp I, Spannagl M, Kauke T, Dick A | Group-specific amplification of HLA-DQA1 revealed a number of genomic full length sequences including the novel HLA alleles DQA1*01:10 and DQA1*01:11 | Tissue Antigens | 2014 | 83 | 49-51 | Dr. Klaus Witter |
DQA1*06:01:01:02 | JM18 | HLA17364 | Suzuki S, Ranade S, Osaki K, Iyo S, Shigenari A, Ohnuki Y, Oka A, Masuya A, Harting J, Baybayan P, Kitazume M, Sunaga J, Morishima S, Morishima Y, Inoko H, Kulski JK, Shiina T | Reference grade characterization of polymorphisms in full-length HLA class I and II genes with short-read sequencing on the ION PGM system and long-reads generated by single molecule, real-time sequencing on the PacBio platform | Frontiers in Immunology | 2018 | 9 | 2294- | Prof. Takashi Shiina |
DQA1*06:01:01:03 | LUY | HLA22524 | Horn GT, Bugawan TL, Long CM, Erlich HA | Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility | Proceedings of the National Academy of Sciences USA | 1988 | 85 | 6012-6016 | Dr. Henry Erlich |
DQA1*06:01:01:03 | LUY | HLA22524 | Yasunaga S, Kimura A, Hamaguchi K, Ronningen KS, Sasazuki T | Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM) | Tissue Antigens | 1996 | 47 | 37-48 | Prof. Akinori Kimura |
DQA1*06:01:01:03 | LUY | HLA22524 | - | - | - | - | - | - | Prof. Steven GE Marsh |
DQA1*06:01:01:04 | LIE | HLA22694 | Turner TR, Hayward DR, Gymer AW, Barker DJ, Leen G, Cambridge CA, Macpherson HL, Georgiou X, Cooper MA, Robinson J, Mayor NP, Marsh SGE | Widespread non-coding polymorphism in HLA class II genes of International HLA and Immunogenetics Workshop cell lines. | HLA | 2022 | 99 | 328-356 | Prof. Steven GE Marsh |
DQA1*06:01:02 | RV | HLA00621 | Schranz P, Albert ED, Renz M, Seelig R, Seelig HP | Nucleotide sequence of a new HLA DQA1*06 allele (DQA1*06012) | Tissue Antigens | 1997 | 50 | 693-694 | Dr. Peter Schranz |
DQA1*06:02 | CDC111803 | HLA01861 | Hancock LN, Cordovado SK, Hendrix M, Simone AE, Mueller PW | Identification of two novel DQA1 alleles, DQA1*0107 and DQA1*0602, by sequence-based typing in the GoKinD population | Human Immunology | 2005 | 66 | 1248-1253 | Dr. Suzanne Cordovado |
DQA1*06:03 | 163UCLA1050 | HLA30944 | - | - | - | - | - | - | Ms. Jessica Etcell |
DQA1*06:03 | HG00029395 | HLA30944 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*06:03 | HG00028884 | HLA30944 | - | - | - | - | - | - | Dr. Nezih Cereb |
DQA1*06:04 | HG00030113 | HLA32061 | - | - | - | - | - | - | Dr. Nezih Cereb |